Chronic	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
infection	O
of	O
myeloid	B-cell_type
cells	I-cell_type
disrupts	O
the	O
autoregulatory	O
control	O
of	O
the	O
NF-kappaB/Rel	B-protein
pathway	O
via	O
enhanced	O
IkappaBalpha	B-protein
degradation	O
.	O

Productive	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
infection	O
causes	O
sustained	O
NF-kappaB	B-protein
DNA-binding	O
activity	O
in	O
chronically	O
infected	O
monocytic	O
cells	O
.	O

A	O
direct	O
temporal	O
correlation	O
exists	O
between	O
HIV	O
infection	O
and	O
the	O
appearance	O
of	O
NF-kappaB	B-protein
DNA-binding	O
activity	O
in	O
myelomonoblastic	B-cell_line
PLB-985	I-cell_line
cells	I-cell_line
.	O

To	O
examine	O
the	O
molecular	O
basis	O
of	O
constitutive	O
NF-kappaB	B-protein
DNA-binding	O
activity	O
in	O
HIV1	B-cell_type
-infected	I-cell_type
cells	I-cell_type
,	O
we	O
analyzed	O
the	O
phosphorylation	O
and	O
turnover	O
of	O
IkappaBalpha	B-protein
protein	O
,	O
the	O
activity	O
of	O
the	O
double-stranded	B-protein
RNA-dependent	I-protein
protein	I-protein
kinase	I-protein
(	O
PKR	B-protein
)	O
and	O
the	O
intracellular	O
levels	O
of	O
NF-kappaB	B-protein
subunits	I-protein
in	O
the	O
PLB-985	B-cell_line
and	O
U937	B-cell_line
myeloid	I-cell_line
cell	I-cell_line
models	I-cell_line
.	O

HIV-1	O
infection	O
resulted	O
in	O
constitutive	O
,	O
low-level	O
expression	O
of	O
type	B-protein
1	I-protein
interferon	I-protein
(	O
IFN	B-protein
)	O
at	O
the	O
mRNA	O
level	O
.	O

Constitutive	O
PKR	B-protein
activity	O
was	O
also	O
detected	O
in	O
HIV-1-infected	B-cell_line
cells	I-cell_line
as	O
a	O
result	O
of	O
low-level	O
IFN	B-protein
production	O
,	O
since	O
the	O
addition	O
of	O
anti-IFN-alpha/beta	B-protein
antibody	I-protein
to	O
the	O
cells	O
decreased	O
PKR	B-protein
expression	O
.	O

Furthermore	O
,	O
the	O
analysis	O
of	O
IkappaBalpha	B-protein
turnover	O
demonstrated	O
an	O
increased	O
degradation	O
of	O
IkappaBalpha	B-protein
in	O
HIV-1-infected	B-cell_line
cells	I-cell_line
that	O
may	O
account	O
for	O
the	O
constitutive	B-DNA
DNA	I-DNA
binding	O
activity	O
.	O

A	O
dramatic	O
increase	O
in	O
the	O
intracellular	O
levels	O
of	O
NF-kappaB	B-protein
subunits	O
c-Rel	B-protein
and	O
NF-kappaB2	B-protein
p100	I-protein
and	O
a	O
moderate	O
increase	O
in	O
NF-kappaB2	B-protein
p52	I-protein
and	O
RelA	B-protein
(	I-protein
p65	I-protein
)	I-protein
were	O
detected	O
in	O
HIV-1-infected	B-cell_line
cells	I-cell_line
,	O
whereas	O
NF-kappaB1	B-protein
p105/p50	I-protein
levels	O
were	O
not	O
altered	O
relative	O
to	O
the	O
levels	O
in	O
uninfected	B-cell_type
cells	I-cell_type
.	O

We	O
suggest	O
that	O
HIV-1	O
infection	O
of	O
myeloid	B-cell_type
cells	I-cell_type
induces	O
IFN	B-protein
production	O
and	O
PKR	B-protein
activity	O
,	O
which	O
in	O
turn	O
contribute	O
to	O
enhanced	O
IkappaBalpha	B-protein
phosphorylation	O
and	O
subsequent	O
degradation	O
.	O

Nuclear	O
translocation	O
of	O
NF-kappaB	B-protein
subunits	I-protein
may	O
ultimately	O
increase	O
the	O
intracellular	O
pool	O
of	O
NF-kappaB/IkappaBalpha	B-protein
by	O
an	O
autoregulatory	O
mechanism	O
.	O

Enhanced	O
turnover	O
of	O
IkappaBalpha	B-protein
and	O
the	O
accumulation	O
of	O
NF-kappaB/Rel	B-protein
proteins	I-protein
may	O
contribute	O
to	O
the	O
chronically	O
activated	O
state	O
of	O
HIV-1-infected	B-cell_line
cells	I-cell_line
.	O

JOURNAL	NULL
or	NULL
VIROLOGY	NULL
,	NULL
Aug.	NULL
1996	NULL
,	NULL
p.	NULL
5183-5193	NULL
0022-538	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

70	NULL
,	NULL
No	NULL
.	NULL

8	NULL
Chronic	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Type	NULL
1	NULL
Infection	NULL
of	NULL
Myeloid	NULL
Cells	NULL
Disrupts	NULL
the	NULL
Autoregulatory	NULL
Control	NULL
of	NULL
the	NULL
NF-kB/Rel	NULL
Pathway	NULL
via	NULL
Enhanced	NULL
IxBa	NULL
Degradation	NULL
CARMELA	NULL
DeELUCA	NULL
,	NULL
***	NULL
``	NULL
ANNE	NULL
ROULSTON	NULL
,	NULL
*+	NULL
ANTONIS	NULL
KOROMILAS	NULL
,	NULL
**	NULL
MARK	NULL
A.	NULL
WAINBERG	NULL
,	NULL
*	NULL
>	NULL
>	NULL
*	NULL
anp	NULL
JOHN	NULL
HISCOTT~	NULL
>	NULL
**	NULL
Lady	NULL
Davis	NULL
Institute	NULL
for	NULL
Medical	NULL
Research	NULL
,	NULL
``	NULL
Sir	NULL
Mortimer	NULL
B.	NULL
Davis	NULL
Jewish	NULL
General	NULL
Hospital	NULL
,	NULL
Departments	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology*	NULL
and	NULL
Medicine	NULL
,	NULL
``	NULL
and	NULL
McGill	NULL
AIDS	NULL
Centre	NULL
,	NULL
``	NULL
McGill	NULL
University	NULL
,	NULL
Montreal	NULL
,	NULL
Quebec	NULL
H3T	NULL
1E2	NULL
,	NULL
Canada	NULL
Received	NULL
31	NULL
October	NULL
1995/Accepted	NULL
16	NULL
May	NULL
1996	NULL
Productive	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
infection	NULL
causes	NULL
sustained	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
in	NULL
chronically	NULL
infected	NULL
monocytic	NULL
cells	NULL
.	NULL

A	NULL
direct	NULL
temporal	NULL
correlation	NULL
exists	NULL
between	NULL
HIV	NULL
infection	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
NF-xB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
myelomonoblastic	NULL
PLB-985	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
constitutive	NULL
NF-xB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
phosphorylation	NULL
and	NULL
turnover	NULL
of	NULL
IxBa	NULL
protein	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
double-stranded	NULL
RNA-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
PKR	NULL
)	NULL
and	NULL
the	NULL
intracellular	NULL
levels	NULL
of	NULL
NF-KB	NULL
subunits	NULL
in	NULL
the	NULL
PLB-985	NULL
and	NULL
U937	NULL
myeloid	NULL
cell	NULL
models	NULL
.	NULL

HIV-1	NULL
infection	NULL
resulted	NULL
in	NULL
constitutive	NULL
,	NULL
low-level	NULL
expression	NULL
of	NULL
type	NULL
1	NULL
interferon	NULL
(	NULL
IFN	NULL
)	NULL
at	NULL
the	NULL
mRNA	NULL
level	NULL
.	NULL

Constitutive	NULL
PKR	NULL
activity	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
as	NULL
a	NULL
result	NULL
of	NULL
low-level	NULL
IFN	NULL
production	NULL
,	NULL
since	NULL
the	NULL
addition	NULL
of	NULL
anti-IFN-	NULL
«	NULL
/B	NULL
antibody	NULL
to	NULL
the	NULL
cells	NULL
decreased	NULL
PKR	NULL
expression	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
analysis	NULL
of	NULL
IxBa	NULL
turnover	NULL
demonstrated	NULL
an	NULL
increased	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
HIV-l-infected	NULL
cells	NULL
that	NULL
may	NULL
account	NULL
for	NULL
the	NULL
constitutive	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

A	NULL
dramatic	NULL
increase	NULL
in	NULL
the	NULL
intracellular	NULL
levels	NULL
of	NULL
NF-B	NULL
subunits	NULL
c-Rel	NULL
and	NULL
NF-B2	NULL
p100	NULL
and	NULL
a	NULL
moderate	NULL
increase	NULL
in	NULL
NF-B2	NULL
p52	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
were	NULL
detected	NULL
in	NULL
HIV-l-infected	NULL
cells	NULL
,	NULL
whereas	NULL
NF-B1	NULL
p105/p50	NULL
levels	NULL
were	NULL
not	NULL
altered	NULL
relative	NULL
to	NULL
the	NULL
levels	NULL
in	NULL
uninfected	NULL
cells	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
HIV-1	NULL
infection	NULL
of	NULL
myeloid	NULL
cells	NULL
induces	NULL
IFN	NULL
production	NULL
and	NULL
PKR	NULL
activity	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
contribute	NULL
to	NULL
enhanced	NULL
IxBa	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
degradation	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
NF-KB	NULL
subunits	NULL
may	NULL
ultimately	NULL
increase	NULL
the	NULL
intracellular	NULL
pool	NULL
of	NULL
NF-KB/IBa	NULL
by	NULL
an	NULL
autoregulatory	NULL
mechanism	NULL
.	NULL

Enhanced	NULL
turnover	NULL
of	NULL
IBa	NULL
and	NULL
the	NULL
accumulation	NULL
of	NULL
NF-B/Rel	NULL
proteins	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
chronically	NULL
activated	NULL
state	NULL
of	NULL
HIV-l-infected	NULL
cells	NULL
.	NULL

CD4*	NULL
myeloid	NULL
cells	NULL
are	NULL
important	NULL
targets	NULL
for	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
infection	NULL
and	NULL
are	NULL
susceptible	NULL
to	NULL
infection	NULL
at	NULL
multiple	NULL
stages	NULL
of	NULL
differentiation	NULL
(	NULL
38	NULL
,	NULL
53	NULL
)	NULL
.	NULL

HIV	NULL
infection	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
in	NULL
vivo	NULL
occurs	NULL
predominantly	NULL
in	NULL
terminally	NULL
differentiated	NULL
macrophages	NULL
in	NULL
tissues	NULL
such	NULL
as	NULL
the	NULL
lymph	NULL
nodes	NULL
,	NULL
lung	NULL
,	NULL
skin	NULL
,	NULL
and	NULL
brain	NULL
(	NULL
23	NULL
)	NULL
,	NULL
although	NULL
HIV-1-infected	NULL
myeloid	NULL
precursors	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
AIDS	NULL
patients	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Since	NULL
HIV	NULL
is	NULL
not	NULL
cytopathic	NULL
to	NULL
myeloid	NULL
cells	NULL
,	NULL
these	NULL
cell	NULL
populations	NULL
may	NULL
act	NULL
as	NULL
reservoirs	NULL
of	NULL
HIV	NULL
within	NULL
the	NULL
bone	NULL
marrow	NULL
and	NULL
other	NULL
tissues	NULL
,	NULL
facilitating	NULL
virus	NULL
spread	NULL
and	NULL
accelerating	NULL
disease	NULL
progression	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Physiological	NULL
changes	NULL
associated	NULL
with	NULL
HIV	NULL
infection	NULL
of	NULL
myeloid	NULL
cells	NULL
include	NULL
functional	NULL
alterations	NULL
in	NULL
chemotaxis	NULL
,	NULL
phagocytosis	NULL
,	NULL
lytic	NULL
activity	NULL
,	NULL
antigen	NULL
presentation	NULL
,	NULL
and	NULL
cytokine	NULL
gene	NULL
expression	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
23	NULL
and	NULL
53	NULL
)	NULL
.	NULL

Generally	NULL
,	NULL
constitutive	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
is	NULL
not	NULL
observed	NULL
in	NULL
chronically	NULL
HIV-infected	NULL
THP-1	NULL
,	NULL
PLB-985	NULL
,	NULL
and	NULL
U937	NULL
cell	NULL
models	NULL
.	NULL

Nonetheless	NULL
,	NULL
increases	NULL
in	NULL
cytokine	NULL
mRNA	NULL
levels	NULL
are	NULL
seen	NULL
after	NULL
cellular	NULL
stimulation	NULL
by	NULL
inducers	NULL
such	NULL
as	NULL
lipopolysaccharide	NULL
or	NULL
Sendai	NULL
virus	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
37	NULL
,	NULL
63	NULL
)	NULL
.	NULL

HIV	NULL
infection	NULL
of	NULL
the	NULL
promonocytic	NULL
U937	NULL
cells	NULL
induced	NULL
phenotypic	NULL
changes	NULL
associated	NULL
with	NULL
cellular	NULL
differentiation	NULL
,	NULL
leading	NULL
to	NULL
increased	NULL
virus	NULL
expression	NULL
(	NULL
19	NULL
,	NULL
29	NULL
,	NULL
40	NULL
,	NULL
41	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
chronic	NULL
HIV	NULL
infection	NULL
of	NULL
PLB-985	NULL
cells	NULL
leads	NULL
to	NULL
morphological	NULL
characteristics	NULL
and	NULL
expression	NULL
of	NULL
myeloid-specific	NULL
surface	NULL
markers	NULL
(	NULL
CD14	NULL
and	NULL
c-fms	NULL
)	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Lady	NULL
Davis	NULL
Institute	NULL
for	NULL
Medical	NULL
Research	NULL
,	NULL
3755	NULL
Cote	NULL
Ste	NULL
.	NULL

Catherine	NULL
,	NULL
Montreal	NULL
,	NULL
Quebec	NULL
,	NULL
Canada	NULL
H3T	NULL
1E2	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
514	NULL
)	NULL
340-8260	NULL
,	NULL
ext	NULL
.	NULL

5265	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
514	NULL
)	NULL
340-7576	NULL
.	NULL

¢	NULL
Present	NULL
address	NULL
:	NULL
Chiron	NULL
Corp.	NULL
,	NULL
Emeryville	NULL
,	NULL
CA	NULL
94608	NULL
.	NULL

5183	NULL
consistent	NULL
with	NULL
irreversible	NULL
differentiation	NULL
along	NULL
the	NULL
monocytic	NULL
pathway	NULL
(	NULL
52	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
surface	NULL
receptors	NULL
associated	NULL
with	NULL
differentiation	NULL
and	NULL
activation	NULL
may	NULL
lead	NULL
to	NULL
increased	NULL
responsiveness	NULL
to	NULL
bacteria	NULL
and	NULL
cytokines	NULL
secreted	NULL
by	NULL
neighboring	NULL
cells	NULL
.	NULL

Chronic	NULL
HIV	NULL
infection	NULL
of	NULL
myeloid	NULL
cells	NULL
may	NULL
also	NULL
alter	NULL
signaling	NULL
pathways	NULL
that	NULL
modulate	NULL
the	NULL
host	NULL
inflammatory	NULL
re-sponse	NULL
.	NULL

One	NULL
of	NULL
the	NULL
important	NULL
transcriptional	NULL
pathways	NULL
involves	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
,	NULL
a	NULL
family	NULL
of	NULL
ubiquitous	NULL
transcription	NULL
factors	NULL
that	NULL
participates	NULL
in	NULL
various	NULL
biological	NULL
processes	NULL
including	NULL
immunological	NULL
responsiveness	NULL
,	NULL
lymphoid	NULL
differentiation	NULL
,	NULL
and	NULL
cell	NULL
growth	NULL
regulation	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
53	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B/	NULL
Rel	NULL
proteins	NULL
are	NULL
present	NULL
in	NULL
most	NULL
cell	NULL
types	NULL
in	NULL
an	NULL
inactive	NULL
cytoplasmic	NULL
form	NULL
,	NULL
complexed	NULL
to	NULL
inhibitory	NULL
IxB	NULL
proteins	NULL
.	NULL

NF-kB	NULL
DNA-binding	NULL
activity	NULL
can	NULL
be	NULL
induced	NULL
following	NULL
exposure	NULL
to	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
activating	NULL
agents	NULL
including	NULL
cytokines	NULL
,	NULL
T-cell	NULL
mitogens	NULL
,	NULL
bacterial	NULL
products	NULL
,	NULL
viruses	NULL
,	NULL
and	NULL
double-stranded	NULL
RNA	NULL
(	NULL
dsRNA	NULL
)	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
NF-kB	NULL
requires	NULL
the	NULL
disruption	NULL
of	NULL
IxB-DNA-binding	NULL
subunit	NULL
interactions	NULL
,	NULL
which	NULL
is	NULL
mediated	NULL
by	NULL
phosphorylation	NULL
of	NULL
IxB	NULL
followed	NULL
by	NULL
proteolytic	NULL
degradation	NULL
via	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
(	NULL
1	NULL
,	NULL
12	NULL
,	NULL
15	NULL
,	NULL
39	NULL
,	NULL
61	NULL
)	NULL
.	NULL

The	NULL
cloning	NULL
of	NULL
several	NULL
NF-xB	NULL
genes	NULL
showed	NULL
that	NULL
these	NULL
proteins	NULL
share	NULL
a	NULL
region	NULL
of	NULL
homology	NULL
,	NULL
termed	NULL
the	NULL
NF-kB/Rel/dorsal	NULL
region	NULL
,	NULL
which	NULL
spans	NULL
approximately	NULL
300	NULL
amino	NULL
acids	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
each	NULL
protein	NULL
.	NULL

Two	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunits	NULL
are	NULL
synthesized	NULL
as	NULL
inactive	NULL
cytoplasmic	NULL
precursor	NULL
proteins	NULL
.	NULL

The	NULL
product	NULL
of	NULL
the	NULL
nfkbl	NULL
gene	NULL
is	NULL
a	NULL
105-kDa	NULL
protein	NULL
which	NULL
gives	NULL
rise	NULL
to	NULL
a	NULL
50-kDa	NULL
DNA-binding	NULL
subunit	NULL
,	NULL
p50	NULL
(	NULL
10	NULL
,	NULL
25	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
nfkb2-encoded	NULL
p100	NULL
precursor	NULL
is	NULL
very	NULL
similar	NULL
to	NULL
p105	NULL
,	NULL
5184	NULL
DELUCA	NULL
ET	NULL
AL	NULL
.	NULL

and	NULL
its	NULL
mature	NULL
DNA-binding	NULL
form	NULL
is	NULL
p52	NULL
.	NULL

The	NULL
other	NULL
NF-	NULL
«	NULL
B/	NULL
Rel	NULL
DNA-binding	NULL
proteins	NULL
are	NULL
not	NULL
processed	NULL
from	NULL
precursors	NULL
:	NULL
c-Rel	NULL
is	NULL
an	NULL
85-kDa	NULL
protein	NULL
,	NULL
which	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B/	NULL
Rel/dorsal	NULL
region	NULL
,	NULL
contains	NULL
a	NULL
unique	NULL
300-amino-acid	NULL
carboxy	NULL
terminal	NULL
domain	NULL
that	NULL
is	NULL
related	NULL
to	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
11	NULL
,	NULL
24	NULL
)	NULL
encoded	NULL
by	NULL
the	NULL
rela	NULL
gene	NULL
.	NULL

The	NULL
carboxy	NULL
termini	NULL
of	NULL
c-Rel	NULL
and	NULL
RelA	NULL
contain	NULL
two	NULL
activation	NULL
domains	NULL
similar	NULL
to	NULL
VP16	NULL
(	NULL
5	NULL
,	NULL
20	NULL
,	NULL
44	NULL
,	NULL
59	NULL
)	NULL
.	NULL

RelB	NULL
is	NULL
also	NULL
structurally	NULL
similar	NULL
to	NULL
RelA	NULL
and	NULL
c-Rel	NULL
but	NULL
lacks	NULL
trans-activating	NULL
potential	NULL
and	NULL
has	NULL
an	NULL
elongated	NULL
amino-terminal	NULL
segment	NULL
(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
IxB	NULL
family	NULL
of	NULL
proteins	NULL
is	NULL
defined	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
NF-	NULL
«	NULL
B/Rel	NULL
subunits	NULL
,	NULL
sequestering	NULL
them	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
possibly	NULL
in	NULL
association	NULL
with	NULL
cytoskeletal	NULL
proteins	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
IxB	NULL
proteins	NULL
so	NULL
far	NULL
identified	NULL
contain	NULL
between	NULL
five	NULL
and	NULL
seven	NULL
repeats	NULL
of	NULL
a	NULL
33-amino-acid	NULL
sequence	NULL
termed	NULL
the	NULL
ankyrin	NULL
motif	NULL
.	NULL

The	NULL
nuclear	NULL
localization	NULL
signal	NULL
in	NULL
the	NULL
NF-kB/Rel/dorsal	NULL
domain	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
is	NULL
necessary	NULL
for	NULL
this	NULL
interaction	NULL
and	NULL
is	NULL
masked	NULL
by	NULL
IxB	NULL
in	NULL
the	NULL
complex	NULL
(	NULL
8	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
include	NULL
,	NULL
IxBa	NULL
,	NULL
IxBB	NULL
,	NULL
IxBy	NULL
,	NULL
the	NULL
proto-onco-gene	NULL
bei-3	NULL
,	NULL
and	NULL
the	NULL
precursors	NULL
p105	NULL
and	NULL
p100	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
7	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
productive	NULL
virus	NULL
infection	NULL
causes	NULL
sustained	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
chronically	NULL
HIV-infected	NULL
monocytic	NULL
cell	NULL
lines	NULL
(	NULL
2	NULL
,	NULL
42	NULL
,	NULL
47	NULL
,	NULL
50	NULL
,	NULL
52	NULL
,	NULL
60	NULL
)	NULL
.	NULL

A	NULL
direct	NULL
temporal	NULL
correlation	NULL
exists	NULL
between	NULL
HIV	NULL
infection	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
the	NULL
myelomonoblastic	NULL
PLB-985	NULL
cells	NULL
(	NULL
51	NULL
,	NULL
52	NULL
)	NULL
.	NULL

One	NULL
common	NULL
point	NULL
at	NULL
which	NULL
the	NULL
infection	NULL
cycle	NULL
of	NULL
many	NULL
viruses	NULL
may	NULL
overlap	NULL
is	NULL
with	NULL
the	NULL
generation	NULL
of	NULL
dsRNA	NULL
during	NULL
replication	NULL
which	NULL
may	NULL
in	NULL
turn	NULL
activate	NULL
the	NULL
dsRNA-dependent	NULL
kinase	NULL
(	NULL
PKR	NULL
)	NULL
(	NULL
34	NULL
,	NULL
58	NULL
)	NULL
.	NULL

PKR	NULL
is	NULL
induced	NULL
by	NULL
interferon	NULL
(	NULL
IFN	NULL
)	NULL
and	NULL
is	NULL
activated	NULL
by	NULL
binding	NULL
to	NULL
dsRNA	NULL
molecules	NULL
synthesized	NULL
during	NULL
viral	NULL
infection	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
a	NULL
well-characterized	NULL
effect	NULL
on	NULL
host	NULL
translation	NULL
,	NULL
PKR	NULL
is	NULL
implicated	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

PKR	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
IxBa	NULL
and	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
in	NULL
cellular	NULL
extracts	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
is	NULL
not	NULL
activated	NULL
by	NULL
dsRNA	NULL
[	NULL
poly	NULL
(	NULL
rl	NULL
)	NULL
:	NULL
poly	NULL
(	NULL
rC	NULL
)	NULL
]	NULL
in	NULL
HeLa	NULL
cells	NULL
depleted	NULL
of	NULL
PKR	NULL
by	NULL
a	NULL
novel	NULL
antisense	NULL
method	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
examine	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
constitutive	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
individual	NULL
NF-kB	NULL
subunits	NULL
,	NULL
IxBa	NULL
turnover	NULL
,	NULL
and	NULL
PKR	NULL
expression	NULL
in	NULL
the	NULL
PLB-985	NULL
and	NULL
U937	NULL
cell	NULL
models	NULL
.	NULL

Our	NULL
results	NULL
demonstrated	NULL
increased	NULL
intracellular	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
c-Rel	NULL
and	NULL
NF-	NULL
«	NULL
B2	NULL
and	NULL
increased	NULL
turnover	NULL
of	NULL
IxBa	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
.	NULL

We	NULL
also	NULL
identified	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
increased	NULL
levels	NULL
of	NULL
PKR	NULL
protein	NULL
and	NULL
activity	NULL
which	NULL
was	NULL
elevated	NULL
by	NULL
constitutive	NULL
low-level	NULL
IFN	NULL
production	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
anti-IFN-	NULL
«	NULL
/B	NULL
antibody	NULL
to	NULL
the	NULL
cells	NULL
decreased	NULL
PKR	NULL
by	NULL
48	NULL
h	NULL
after	NULL
the	NULL
addition	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
HIV-1	NULL
infection	NULL
of	NULL
myeloid	NULL
cells	NULL
induces	NULL
IFN	NULL
production	NULL
and	NULL
PKR	NULL
activity	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
contributes	NULL
to	NULL
enhanced	NULL
IxBa	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
degradation	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
subunits	NULL
may	NULL
ultimately	NULL
increase	NULL
the	NULL
intracellular	NULL
pool	NULL
of	NULL
NF-kB/IxBa	NULL
by	NULL
an	NULL
autoregulatory	NULL
mechanism	NULL
.	NULL

The	NULL
increased	NULL
pool	NULL
of	NULL
NF-	NULL
«	NULL
B/IkxBa	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
chronically	NULL
activated	NULL
state	NULL
of	NULL
HIV-1-infected	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
.	NULL

Myelomonoblastic	NULL
PLB-985	NULL
and	NULL
U937	NULL
cells	NULL
and	NULL
PLB-IIIB	NULL
and	NULL
U9-IIIB	NULL
cells	NULL
,	NULL
infected	NULL
with	NULL
HIV	NULL
strain	NULL
IIIB	NULL
,	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
GIBCO	NULL
,	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
N.Y.	NULL
)	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
Fetal	NULL
Clone	NULL
(	NULL
Hyclone	NULL
,	NULL
Logan	NULL
,	NULL
Utah	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
gentamicin	NULL
(	NULL
Schering	NULL
Canada	NULL
,	NULL
Pointe	NULL
Claire	NULL
,	NULL
Quebec	NULL
,	NULL
Canada	NULL
)	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
50	NULL
ng	NULL
of	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
;	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
ug	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-a	NULL
;	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
1,000	NULL
IU	NULL
of	NULL
IFN	NULL
(	NULL
Schering	NULL
Canada	NULL
)	NULL
per	NULL
ml	NULL
or	NULL
1,000	NULL
new	NULL
units	NULL
(	NULL
NU	NULL
)	NULL
of	NULL
anti-leukocyte	NULL
IFN	NULL
anti	NULL
J.	NULL
ViroL	NULL
.	NULL

body	NULL
(	NULL
anti-IFN-/8	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
in	NULL
the	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
seeded	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
and	NULL
stimulated	NULL
for	NULL
different	NULL
times	NULL
depending	NULL
on	NULL
the	NULL
experiment	NULL
.	NULL

S1	NULL
nuclease	NULL
analysis	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
from	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
was	NULL
isolated	NULL
at	NULL
specific	NULL
time	NULL
points	NULL
after	NULL
infection	NULL
according	NULL
to	NULL
a	NULL
modified	NULL
guanidium	NULL
isothiocyanate	NULL
procedure	NULL
.	NULL

Si-mapping	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
40	NULL
ug	NULL
of	NULL
RNA	NULL
and	NULL
5	NULL
'	NULL
[	NULL
y-*	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
end-labeled	NULL
probes	NULL
specific	NULL
for	NULL
IFN-a1	NULL
and	NULL
IFN-B	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Nuclease-resistant	NULL
DNA/RNA	NULL
hybrid	NULL
molecules	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
6	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
quantified	NULL
by	NULL
laser	NULL
densitometry	NULL
,	NULL
and	NULL
expressed	NULL
as	NULL
relative	NULL
RNA	NULL
levels	NULL
.	NULL

Assay	NULL
for	NULL
PKR	NULL
activity	NULL
.	NULL

PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
were	NULL
concentrated	NULL
to	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
ml	NULL
and	NULL
incubated	NULL
with	NULL
Sendai	NULL
virus	NULL
(	NULL
100	NULL
hemagglutinating	NULL
units	NULL
per	NULL
ml	NULL
)	NULL
for	NULL
90	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Mock-infected	NULL
cells	NULL
were	NULL
concentrated	NULL
as	NULL
described	NULL
above	NULL
but	NULL
incubated	NULL
without	NULL
virus	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
subsequently	NULL
diluted	NULL
to	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
and	NULL
incubated	NULL
for	NULL
a	NULL
total	NULL
of	NULL
6	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
with	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.2	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
,	NULL
3	NULL
g	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

Extracts	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
anti-PKR	NULL
antibody	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Anti-mouse	NULL
immuno-globulin	NULL
G-agarose	NULL
beads	NULL
were	NULL
added	NULL
to	NULL
the	NULL
extracts	NULL
and	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
high-salt	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
400	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.2	NULL
mM	NULL
PMSF	NULL
,	NULL
3	NULL
ug	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
1	NULL
g	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
)	NULL
followed	NULL
by	NULL
three	NULL
washes	NULL
with	NULL
low-salt	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithic-threitol	NULL
,	NULL
0.2	NULL
mM	NULL
PMSF	NULL
,	NULL
3	NULL
pg	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
1	NULL
pg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

PKR	NULL
activity	NULL
was	NULL
induced	NULL
by	NULL
incubating	NULL
the	NULL
beads	NULL
with	NULL
0.1	NULL
g	NULL
of	NULL
poly	NULL
(	NULL
rC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
per	NULL
ml	NULL
in	NULL
5	NULL
%	NULL
kinase	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.7	NULL
]	NULL
,	NULL
250	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
25	NULL
mM	NULL
B-mercapto-ethanol	NULL
)	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
then	NULL
incubated	NULL
at	NULL
30°C	NULL
for	NULL
30	NULL
min	NULL
with	NULL
[	NULL
y-*P	NULL
]	NULL
JATP	NULL
(	NULL
ICN	NULL
)	NULL
to	NULL
detect	NULL
autophosphorylation	NULL
.	NULL

PKR	NULL
was	NULL
solubilized	NULL
with	NULL
2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
sample	NULL
buffer	NULL
and	NULL
run	NULL
on	NULL
an	NULL
8	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
fixed	NULL
with	NULL
10	NULL
%	NULL
methanol-5	NULL
%	NULL
acetic	NULL
acid	NULL
for	NULL
30	NULL
min	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
.	NULL

The	NULL
intensities	NULL
of	NULL
the	NULL
PKR	NULL
bands	NULL
detected	NULL
by	NULL
autoradiography	NULL
were	NULL
quantified	NULL
by	NULL
laser	NULL
densitometry	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Northern	NULL
(	NULL
RNA	NULL
)	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
10	NULL
to	NULL
20	NULL
pg	NULL
)	NULL
was	NULL
electrophoresed	NULL
in	NULL
a	NULL
1	NULL
%	NULL
denaturing	NULL
formaldehyde	NULL
agarose	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
(	NULL
Hybond-N	NULL
;	NULL
Amersham	NULL
)	NULL
with	NULL
a	NULL
Vacu-Gene	NULL
blotting	NULL
system	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
cross-linked	NULL
to	NULL
the	NULL
membrane	NULL
in	NULL
a	NULL
UV	NULL
Stratalinker	NULL
2400	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
and	NULL
prehybridized	NULL
overnight	NULL
in	NULL
prehybridization	NULL
solution	NULL
{	NULL
25	NULL
mM	NULL
KPO	NULL
,	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
5x	NULL
SSC	NULL
(	NULL
750	NULL
mM	NULL
NaCl	NULL
,	NULL
75	NULL
mM	NULL
sodium	NULL
citrate	NULL
[	NULL
pH	NULL
7.0	NULL
}	NULL
)	NULL
,	NULL
50	NULL
%	NULL
deionized	NULL
formamide	NULL
,	NULL
50	NULL
ug	NULL
of	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
Boehringer	NULL
GmbH	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
}	NULL
and	NULL
5	NULL
%	NULL
Denhardt	NULL
's	NULL
solution	NULL
containing	NULL
0.5	NULL
%	NULL
Ficoll	NULL
400	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
0.5	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
polyvinylpyrrolidine	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
at	NULL
42°C	NULL
in	NULL
a	NULL
hybridization	NULL
oven	NULL
.	NULL

The	NULL
probes	NULL
used	NULL
included	NULL
a	NULL
0.8-kb	NULL
PKR	NULL
fragment	NULL
generated	NULL
by	NULL
EcoRI	NULL
digestion	NULL
of	NULL
plasmid	NULL
pé8wt-peDNAT	NULL
NEO	NULL
(	NULL
26	NULL
)	NULL
,	NULL
a	NULL
1.1-kb	NULL
fragment	NULL
isolated	NULL
from	NULL
pSVK3-IxBa	NULL
by	NULL
EcoRI	NULL
digestion	NULL
(	NULL
6	NULL
)	NULL
,	NULL
and	NULL
a	NULL
1.1-kb	NULL
fragment	NULL
derived	NULL
from	NULL
pB-actin	NULL
by	NULL
PsfI	NULL
digestion	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
labeled	NULL
to	NULL
approximately	NULL
10°	NULL
epm/pg	NULL
with	NULL
the	NULL
oligolabeling	NULL
kit	NULL
(	NULL
Pharmacia	NULL
)	NULL
and	NULL
[	NULL
a-	NULL
``	NULL
°P	NULL
]	NULL
JCTP	NULL
.	NULL

Hybridization	NULL
occurred	NULL
overnight	NULL
at	NULL
42°C	NULL
in	NULL
prehybridization	NULL
solution	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
dextran	NULL
sulfate	NULL
(	NULL
Pharmacia	NULL
)	NULL
and	NULL
approximately	NULL
5	NULL
x	NULL
10	NULL
``	NULL
cpm	NULL
of	NULL
labeled	NULL
probe	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
washed	NULL
,	NULL
wrapped	NULL
in	NULL
plastic	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
X-Omat	NULL
film	NULL
(	NULL
Kodak	NULL
)	NULL
at	NULL
-70°C	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
NF-xB/IxB	NULL
proteins	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
resuspension	NULL
in	NULL
Nonidet	NULL
P-40	NULL
(	NULL
NP-40	NULL
)	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
0.01	NULL
mg	NULL
each	NULL
of	NULL
leupeptin	NULL
,	NULL
pepstatin	NULL
,	NULL
and	NULL
aprotinin	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
,	NULL
cellular	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Cell	NULL
extracts	NULL
(	NULL
10	NULL
to	NULL
20	NULL
ug	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
and	NULL
then	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
blocked	NULL
for	NULL
a	NULL
minimum	NULL
of	NULL
2	NULL
h	NULL
in	NULL
5	NULL
%	NULL
skim	NULL
milk	NULL
and	NULL
incubated	NULL
overnight	NULL
in	NULL
5	NULL
%	NULL
milk	NULL
containing	NULL
affinity-purified	NULL
,	NULL
anti-peptide	NULL
polyclonal	NULL
antisera	NULL
(	NULL
dilutions	NULL
ranged	NULL
from	NULL
1:250	NULL
to	NULL
1:1,000	NULL
)	NULL
.	NULL

Antisera	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Antibody	NULL
AR27	NULL
or	NULL
anti-p105-N	NULL
was	NULL
raised	NULL
against	NULL
a	NULL
peptide	NULL
(	NULL
amino	NULL
acids	NULL
2	NULL
to	NULL
15	NULL
)	NULL
at	NULL
the	NULL
most-N-terminal	NULL
region	NULL
of	NULL
p105	NULL
and	NULL
recognizes	NULL
both	NULL
p105	NULL
and	NULL
p50	NULL
;	NULL
AR43	NULL
or	NULL
anti-p100-N	NULL
was	NULL
generated	NULL
against	NULL
a	NULL
peptide	NULL
at	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
p100	NULL
(	NULL
amino	NULL
acids	NULL
2	NULL
to	NULL
17	NULL
)	NULL
and	NULL
recognizes	NULL
both	NULL
p100	NULL
and	NULL
p52	NULL
;	NULL
AR28	NULL
recognizes	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
p65	NULL
(	NULL
amino	NULL
acids	NULL
537	NULL
to	NULL
550	NULL
)	NULL
;	NULL
AR22	NULL
recognizes	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
c-Rel	NULL
(	NULL
amino	NULL
acid	NULL
573	NULL
to	NULL
587	NULL
)	NULL
.	NULL

AR20	NULL
recognizes	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
IxBa	NULL
(	NULL
aa2	NULL
to	NULL
16	NULL
)	NULL
.	NULL

Antiserum	NULL
that	NULL
recognizes	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
,	NULL
Inc	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
rinsed	NULL
four	NULL
times	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
secondary	NULL
antibody	NULL
,	NULL
flu-orescein	NULL
isothiocyanate-conjugated	NULL
goat	NULL
anti-rabbit	NULL
(	NULL
1:1,000	NULL
;	NULL
Amersham	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
rinsed	NULL
again	NULL
four	NULL
times	NULL
in	NULL
PBS	NULL
.	NULL

The	NULL
enhanced	NULL
chemiluminescence-Western	NULL
blotting	NULL
(	NULL
immunoblotting	NULL
)	NULL
detection	NULL
system	NULL
(	NULL
Am-ersham	NULL
)	NULL
was	NULL
used	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
to	NULL
visualize	NULL
the	NULL
specific	NULL
signals	NULL
.	NULL

Autoradiograms	NULL
were	NULL
scanned	NULL
by	NULL
laser	NULL
densitometry	NULL
,	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
each	NULL
band	NULL
is	NULL
presented	NULL
relative	NULL
to	NULL
the	NULL
levels	NULL
in	NULL
uninfected	NULL
,	NULL
unstimulated	NULL
cells	NULL
for	NULL
NF-kB	NULL
subunits	NULL
;	NULL
quantification	NULL
of	NULL
IxBa	NULL
«	NULL
was	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
IxBa	NULL
remaining	NULL
relative	NULL
to	NULL
the	NULL
amount	NULL
at	NULL
time	NULL
zero	NULL
.	NULL

Values	NULL
for	NULL
turnover	NULL
rates	NULL
were	NULL
plotted	NULL
on	NULL
a	NULL
semi-log	NULL
scale	NULL
,	NULL
and	NULL
the	NULL
best	NULL
fit	NULL
curves	NULL
were	NULL
determined	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
repeated	NULL
a	NULL
minimum	NULL
of	NULL
three	NULL
times	NULL
,	NULL
and	NULL
representative	NULL
autoradiograms	NULL
are	NULL
shown	NULL
.	NULL

voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
-O-	NULL
PLB	NULL
985	NULL
-*-	NULL
PLB	NULL
IIIB	NULL
0.87	NULL
0.67	NULL
0.47	NULL
Relative	NULL
IFNol	NULL
mRNA	NULL
Levels	NULL
0.27	NULL
€	NULL
0.0	NULL
0-0	NULL
t	NULL
t	NULL
1	NULL
0	NULL
10	NULL
20	NULL
30	NULL
Time	NULL
(	NULL
Hours	NULL
post	NULL
infection	NULL
)	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Kinetics	NULL
of	NULL
IFN	NULL
mRNA	NULL
expression	NULL
in	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
after	NULL
infection	NULL
with	NULL
Sendai	NULL
paramyxovirus	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
at	NULL
hours	NULL
0	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
10	NULL
,	NULL
12	NULL
,	NULL
16	NULL
,	NULL
and	NULL
24	NULL
following	NULL
Sendai	NULL
virus	NULL
infection	NULL
.	NULL

S1	NULL
mapping	NULL
was	NULL
performed	NULL
with	NULL
40	NULL
ug	NULL
of	NULL
cellular	NULL
mRNA	NULL
and	NULL
an	NULL
[	NULL
y-	NULL
``	NULL
°P	NULL
]	NULL
ATP	NULL
end-labeled	NULL
IFN-	NULL
«	NULL
1-	NULL
and	NULL
IFN-B-specific	NULL
probes	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
22	NULL
,	NULL
51	NULL
)	NULL
;	NULL
signals	NULL
corresponding	NULL
to	NULL
RNA-DNA	NULL
hybrids	NULL
were	NULL
identified	NULL
by	NULL
autoradiography	NULL
,	NULL
and	NULL
the	NULL
intensities	NULL
of	NULL
the	NULL
bands	NULL
corresponding	NULL
to	NULL
the	NULL
IFN-	NULL
«	NULL
1	NULL
and	NULL
IFN-B	NULL
signals	NULL
were	NULL
scanned	NULL
by	NULL
laser	NULL
densitometry	NULL
and	NULL
plotted	NULL
in	NULL
terms	NULL
of	NULL
relative	NULL
mRNA	NULL
levels	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
IFN-a1	NULL
are	NULL
illustrated	NULL
and	NULL
are	NULL
qualitatively	NULL
similar	NULL
to	NULL
results	NULL
obtained	NULL
for	NULL
IFN-B	NULL
.	NULL

Detection	NULL
of	NULL
IxBa	NULL
«	NULL
phosphorylation	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
for	NULL
Western	NULL
blot	NULL
analysis	NULL
and	NULL
treated	NULL
with	NULL
0.5	NULL
U	NULL
of	NULL
potato	NULL
acid	NULL
phosphatase	NULL
in	NULL
PIPES	NULL
[	NULL
piperazine-N	NULL
,	NULL
V	NULL
'	NULL
-bis	NULL
(	NULL
2-ethanesulfonic	NULL
acid	NULL
)	NULL
]	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
PIPES	NULL
[	NULL
pH	NULL
6.0	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
5	NULL
g	NULL
each	NULL
of	NULL
leupeptin	NULL
,	NULL
pepstatin	NULL
,	NULL
and	NULL
aprotinin	NULL
per	NULL
ml	NULL
)	NULL
or	NULL
with	NULL
0.5	NULL
U	NULL
of	NULL
potato	NULL
acid	NULL
phosphatase	NULL
in	NULL
PIPES	NULL
buffer	NULL
plus	NULL
inhibitor	NULL
mix	NULL
(	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
1.5	NULL
mM	NULL
Na	NULL
,	NULL
MoO	NULL
,	NULL
,	NULL
0.4	NULL
mM	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
0.1	NULL
ug	NULL
of	NULL
okadaic	NULL
acid	NULL
per	NULL
ml	NULL
)	NULL
at	NULL
37°C	NULL
for	NULL
60	NULL
min	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
protein	NULL
(	NULL
50	NULL
pg	NULL
)	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
5	NULL
to	NULL
13	NULL
%	NULL
gradient	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

IxBo	NULL
and	NULL
phosphorylated	NULL
IxBa	NULL
were	NULL
visualized	NULL
with	NULL
the	NULL
previously	NULL
described	NULL
affinity-purified	NULL
IxBa	NULL
antibody	NULL
(	NULL
AR20	NULL
)	NULL
.	NULL

In	NULL
other	NULL
experiments	NULL
,	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
in	NULL
log	NULL
phase	NULL
growth	NULL
were	NULL
concentrated	NULL
to	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
and	NULL
were	NULL
incubated	NULL
with	NULL
25	NULL
uM	NULL
MG132	NULL
(	NULL
Myogenics	NULL
)	NULL
or	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
dimethyl	NULL
sulfoxide	NULL
(	NULL
DMSO	NULL
)	NULL
for	NULL
0	NULL
to	NULL
120	NULL
min	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
SDS-5	NULL
to	NULL
13	NULL
%	NULL
polyacrylamide	NULL
gradient	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
for	NULL
immunoblot	NULL
analysis	NULL
.	NULL

Phosphorylated	NULL
IxBa	NULL
was	NULL
detected	NULL
as	NULL
a	NULL
distinct	NULL
more	NULL
slowly	NULL
migrating	NULL
band	NULL
with	NULL
a	NULL
monoclonal	NULL
IxBa	NULL
«	NULL
peptide	NULL
antibody	NULL
(	NULL
49	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
kB/Rel	NULL
REGULATION	NULL
IN	NULL
HIV-1-INFECTED	NULL
MYELOID	NULL
CELLS	NULL
5185	NULL
RESULTS	NULL
Altered	NULL
kinetics	NULL
of	NULL
IFN	NULL
gene	NULL
expression	NULL
.	NULL

HIV	NULL
infection	NULL
leads	NULL
to	NULL
the	NULL
dysregulation	NULL
of	NULL
numerous	NULL
cytokine	NULL
genes	NULL
(	NULL
53	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
IFN	NULL
production	NULL
was	NULL
affected	NULL
,	NULL
a	NULL
kinetic	NULL
analysis	NULL
of	NULL
IFN-a1	NULL
and	NULL
IFN-	NULL
gene	NULL
transcription	NULL
was	NULL
performed	NULL
with	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

S1-mapping	NULL
analysis	NULL
with	NULL
probes	NULL
corresponding	NULL
to	NULL
IFN-B	NULL
and	NULL
IFN-	NULL
«	NULL
1	NULL
demonstrated	NULL
that	NULL
chronically	NULL
infected	NULL
PLB-IIIB	NULL
cells	NULL
constitutively	NULL
expressed	NULL
low	NULL
levels	NULL
of	NULL
IFNa1	NULL
mRNA	NULL
and	NULL
IFN-	NULL
mRNA	NULL
(	NULL
51	NULL
,	NULL
52	NULL
)	NULL
.	NULL

When	NULL
coin-fected	NULL
with	NULL
Sendai	NULL
virus	NULL
,	NULL
PLB-IIIB	NULL
cells	NULL
exhibited	NULL
an	NULL
altered	NULL
pattern	NULL
of	NULL
IFN	NULL
gene	NULL
expression	NULL
compared	NULL
with	NULL
de	NULL
novo	NULL
Sendai	NULL
virus	NULL
infection	NULL
of	NULL
PLB-985	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Sendai	NULL
virus-induced	NULL
IFN	NULL
mRNA	NULL
from	NULL
PLB-IIIB	NULL
cells	NULL
increased	NULL
at	NULL
1	NULL
h	NULL
postinfection	NULL
(	NULL
p.i	NULL
.	NULL
)	NULL

,	NULL
reached	NULL
a	NULL
peak	NULL
at	NULL
4	NULL
to	NULL
6	NULL
h	NULL
p.i	NULL
.	NULL

,	NULL
and	NULL
then	NULL
decreased	NULL
to	NULL
constitutive	NULL
levels	NULL
by	NULL
10	NULL
h	NULL
p.i	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Sendai	NULL
virus-induced	NULL
IFN	NULL
mRNA	NULL
from	NULL
PLB-985	NULL
cells	NULL
was	NULL
initially	NULL
detected	NULL
at	NULL
6	NULL
h	NULL
p.i	NULL
.	NULL

and	NULL
reached	NULL
a	NULL
peak	NULL
at	NULL
10	NULL
to	NULL
16	NULL
h	NULL
p.i	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
demonstrated	NULL
three	NULL
distinct	NULL
alterations	NULL
in	NULL
IFN	NULL
induction	NULL
:	NULL
(	NULL
i	NULL
)	NULL
a	NULL
constitutive	NULL
level	NULL
of	NULL
transcription	NULL
in	NULL
chronically	NULL
HIV-1-infected	NULL
PLB-IIIB	NULL
cells	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
rapid	NULL
induction	NULL
kinetics	NULL
in	NULL
Sendai	NULL
virus-infected	NULL
PLB-IIIB	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
PLB-985	NULL
cells	NULL
;	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
a	NULL
lower	NULL
relative	NULL
amount	NULL
of	NULL
IFN	NULL
mRNA	NULL
in	NULL
Sendai	NULL
virus-induced	NULL
PLB-IIIB	NULL
cells	NULL
than	NULL
in	NULL
PLB-985	NULL
cells	NULL
.	NULL

Analysis	NULL
of	NULL
PKR	NULL
expression	NULL
and	NULL
activity	NULL
.	NULL

The	NULL
dsRNA-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
PKR	NULL
)	NULL
is	NULL
induced	NULL
by	NULL
IFN	NULL
and	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
natural	NULL
or	NULL
synthetic	NULL
dsRNA	NULL
.	NULL

Since	NULL
recent	NULL
studies	NULL
demonstrated	NULL
that	NULL
PKR	NULL
activated	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
cellular	NULL
extracts	NULL
(	NULL
27	NULL
,	NULL
30	NULL
)	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
examine	NULL
whether	NULL
PKR	NULL
activity	NULL
may	NULL
be	NULL
elevated	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
and	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
IxBa	NULL
phosphorylation	NULL
and	NULL
turnover	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
demonstrated	NULL
a	NULL
constitutive	NULL
level	NULL
of	NULL
PKR	NULL
mRNA	NULL
expression	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
PLB-985	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
PKR	NULL
mRNA	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
increased	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
for	NULL
8	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
but	NULL
not	NULL
in	NULL
response	NULL
to	NULL
Sendai	NULL
virus	NULL
infection	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

In	NULL
other	NULL
experiments	NULL
,	NULL
PKR	NULL
mRNA	NULL
levels	NULL
peaked	NULL
at	NULL
24	NULL
h	NULL
p.i	NULL
.	NULL

in	NULL
PLB-985	NULL
cells	NULL
,	NULL
while	NULL
in	NULL
PLB-IIIB	NULL
PKR	NULL
mRNA	NULL
levels	NULL
were	NULL
constitutively	NULL
elevated	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
level	NULL
of	NULL
PKR	NULL
protein	NULL
was	NULL
increased	NULL
by	NULL
more	NULL
than	NULL
fivefold	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
com	NULL
A	NULL
-	NULL
mRNA	NULL
B	NULL
Protein	NULL
C_	NULL
Activity	NULL
10	NULL
2	NULL
3	NULL
405006	NULL
1	NULL
2	NULL
3	NULL
0	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
«	NULL
iin	NULL
swe	NULL
»	NULL
~	NULL
”	NULL
h	NULL
pra	NULL
w	NULL
#	NULL
-	NULL
Ct	NULL
»	NULL
came	NULL
numa	NULL
Induction	NULL
ILP	NULL
SIIU	NULL
P	NULL
SI	NULL
I	NULL
U	NULL
S	NULL
I	NULL
IU	NULL
S	NULL
I	NULL
LU	NULL
S	NULL
I	NULL
IU	NULL
S	NULL
I	NULL
PLB985	NULL
-	NULL
PLBIIIB	NULL
PLB985	NULL
PLBIIIB	NULL
PLB985	NULL
PLBIIIB	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Analysis	NULL
of	NULL
PKR	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
levels	NULL
in	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
PLB-985	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
or	NULL
PLB-IIIB	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
cells	NULL
that	NULL
were	NULL
untreated	NULL
(	NULL
U	NULL
)	NULL
,	NULL
PMA	NULL
treated	NULL
(	NULL
P	NULL
)	NULL
,	NULL
or	NULL
Sendai	NULL
virus	NULL
infected	NULL
(	NULL
S	NULL
)	NULL
for	NULL
8	NULL
h.	NULL
RNA	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
denaturing	NULL
agarose	NULL
gel	NULL
containing	NULL
ethidium	NULL
bromide	NULL
and	NULL
visualized	NULL
under	NULL
UV	NULL
light	NULL
(	NULL
310	NULL
nm	NULL
)	NULL
.	NULL

After	NULL
RNA	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
a	NULL
PKR	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
2.5-kb	NULL
PKR	NULL
RNA	NULL
transcript	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

(	NULL
B	NULL
)	NULL
PLB-985	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
PLB-IIIB	NULL
cells	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
that	NULL
were	NULL
untreated	NULL
(	NULL
U	NULL
)	NULL
or	NULL
infected	NULL
by	NULL
Sendai	NULL
virus	NULL
for	NULL
6	NULL
h	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
a	NULL
monoclonal	NULL
PKR	NULL
antibody	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
band	NULL
corresponding	NULL
to	NULL
the	NULL
68-kDa	NULL
PKR	NULL
protein	NULL
.	NULL

(	NULL
C	NULL
)	NULL
PLB-985	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
PLB-IIIB	NULL
cells	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
untreated	NULL
(	NULL
U	NULL
)	NULL
or	NULL
infected	NULL
by	NULL
Sendai	NULL
virus	NULL
for	NULL
6	NULL
h	NULL
(	NULL
S	NULL
)	NULL
,	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
a	NULL
polyclonal	NULL
antisera	NULL
against	NULL
PKR	NULL
.	NULL

PKR	NULL
activity	NULL
was	NULL
induced	NULL
by	NULL
poly	NULL
(	NULL
rI	NULL
)	NULL
:	NULL
poly	NULL
(	NULL
rC	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
[	NULL
y-*2P	NULL
]	NULL
ATP	NULL
to	NULL
detect	NULL
autophosphorylation	NULL
.	NULL

The	NULL
signal	NULL
was	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

5186	NULL
DELUCA	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
Inducer	NULL
-P	NULL
TSS	NULL
_	NULL
-	NULL
PTS	NULL
S	NULL
PLB-985	NULL
-	NULL
PLB-IIIB	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1112	NULL
13	NULL
«	NULL
-e-	NULL
-	NULL
-M	NULL
PKR	NULL
-	NULL
»	NULL
Actin	NULL
-	NULL
»	NULL
|	NULL
cone	NULL
cnen	NULL
comm	NULL
mate	NULL
IFN	NULL
topos	NULL
pos	NULL
os	NULL
IFN	NULL
Ab	NULL
_	NULL
-	NULL
-	NULL
+	NULL
#	NULL
~	NULL
-	NULL
+	NULL
#	NULL
=	NULL
-	NULL
=	NULL
--	NULL
+	NULL
985	NULL
IIIB	NULL
-	NULL
985	NULL
IIIB	NULL
24	NULL
hrs	NULL
48	NULL
hrs	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Modulation	NULL
of	NULL
PKR	NULL
protein	NULL
expression	NULL
levels	NULL
in	NULL
PLB-985	NULL
and	NULL
PLB-TIB	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
P	NULL
)	NULL
or	NULL
TNF-a	NULL
(	NULL
T	NULL
)	NULL
or	NULL
were	NULL
Sendai	NULL
(	NULL
8	NULL
)	NULL
virus	NULL
infected	NULL
for	NULL
0	NULL
h	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
,	NULL
6	NULL
h	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
and	NULL
7	NULL
to	NULL
9	NULL
)	NULL
,	NULL
or	NULL
24	NULL
h	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
)	NULL
.	NULL

PKR	NULL
protein	NULL
expression	NULL
is	NULL
identified	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

(	NULL
B	NULL
)	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
(	NULL
+	NULL
or	NULL
-	NULL
,	NULL
respectively	NULL
)	NULL
of	NULL
IFN	NULL
or	NULL
anti-IFN-	NULL
«	NULL
/B	NULL
(	NULL
IFN-Ab	NULL
)	NULL
for	NULL
24	NULL
or	NULL
48	NULL
h.	NULL
The	NULL
immunoblot	NULL
was	NULL
reprobed	NULL
for	NULL
actin	NULL
to	NULL
confirm	NULL
equal	NULL
protein	NULL
loading	NULL
per	NULL
lane	NULL
.	NULL

PKR	NULL
and	NULL
actin	NULL
are	NULL
identified	NULL
by	NULL
arrows	NULL
.	NULL

pared	NULL
with	NULL
that	NULL
in	NULL
PLB-985	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
analysis	NULL
of	NULL
PKR	NULL
autocatalytic	NULL
activity	NULL
demonstrated	NULL
that	NULL
PKR	NULL
activity	NULL
was	NULL
increased	NULL
in	NULL
extracts	NULL
from	NULL
PLB-IIIB	NULL
cells	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
PLB-985	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Darker	NULL
exposures	NULL
revealed	NULL
that	NULL
PKR	NULL
activity	NULL
was	NULL
detectable	NULL
in	NULL
PLB-985	NULL
cell	NULL
extracts	NULL
stimulated	NULL
by	NULL
Sendai	NULL
virus	NULL
infection	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
HIV-infected	NULL
myeloid	NULL
cells	NULL
have	NULL
increased	NULL
PKR	NULL
activity	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
similarly	NULL
treated	NULL
PLB-985	NULL
cells	NULL
.	NULL

Addition	NULL
of	NULL
neutralizing	NULL
IFN	NULL
antibody	NULL
downregulates	NULL
PKR	NULL
levels	NULL
.	NULL

Kinetic	NULL
analysis	NULL
revealed	NULL
that	NULL
PKR	NULL
protein	NULL
levels	NULL
were	NULL
inducible	NULL
in	NULL
PLB-985	NULL
but	NULL
were	NULL
essentially	NULL
constitutive	NULL
in	NULL
PLBIIIB	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3A	NULL
)	NULL
.	NULL

Protein	NULL
levels	NULL
were	NULL
increased	NULL
in	NULL
PLB-985	NULL
cells	NULL
at	NULL
18	NULL
to	NULL
24	NULL
h	NULL
p.i	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
but	NULL
only	NULL
weakly	NULL
elevated	NULL
at	NULL
6	NULL
h	NULL
p.i	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PLB-IIIB	NULL
cells	NULL
had	NULL
high	NULL
PKR	NULL
levels	NULL
at	NULL
various	NULL
time	NULL
points	NULL
between	NULL
0	NULL
and	NULL
48	NULL
h	NULL
after	NULL
treatment	NULL
with	NULL
different	NULL
activators	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
,	NULL
and	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
9	NULL
,	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Since	NULL
IFN	NULL
expression	NULL
may	NULL
lead	NULL
to	NULL
elevated	NULL
levels	NULL
of	NULL
PKR	NULL
in	NULL
chronically	NULL
infected	NULL
cells	NULL
,	NULL
abrogating	NULL
IFN	NULL
signaling	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
neutralizing	NULL
antibody	NULL
may	NULL
decrease	NULL
PKR	NULL
expression	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
anti-IFN-	NULL
«	NULL
/B	NULL
antibody	NULL
would	NULL
affect	NULL
PKR	NULL
expression	NULL
levels	NULL
in	NULL
PLB-IIB	NULL
cells	NULL
,	NULL
1,000	NULL
NU	NULL
of	NULL
anti-leukocyte	NULL
IFN	NULL
(	NULL
anti-IFN	NULL
«	NULL
/B	NULL
)	NULL
J.	NULL
ViroL	NULL
.	NULL

antibody	NULL
per	NULL
ml	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cultures	NULL
.	NULL

PLB-IIIB	NULL
cells	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-IFN	NULL
antibody	NULL
for	NULL
48	NULL
h	NULL
had	NULL
dramatically	NULL
reduced	NULL
levels	NULL
of	NULL
PKR	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
11	NULL
to	NULL
13	NULL
)	NULL
;	NULL
this	NULL
effect	NULL
of	NULL
anti-IFN	NULL
antibody	NULL
required	NULL
more	NULL
than	NULL
24	NULL
h	NULL
to	NULL
be	NULL
established	NULL
,	NULL
since	NULL
changes	NULL
in	NULL
PKR	NULL
levels	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
after	NULL
24	NULL
h	NULL
of	NULL
treatment	NULL
with	NULL
anti-IFN	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
chronic	NULL
HIV-1	NULL
infection	NULL
of	NULL
PLB-985	NULL
cells	NULL
resulted	NULL
in	NULL
low-level	NULL
IFN	NULL
production	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
stimulated	NULL
constitutive	NULL
expression	NULL
of	NULL
PKR	NULL
.	NULL

IxBa	NULL
turnover	NULL
in	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
turnover	NULL
of	NULL
IxBa	NULL
in	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
was	NULL
examined	NULL
by	NULL
immunoblot	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Although	NULL
IxBa	NULL
levels	NULL
were	NULL
slightly	NULL
elevated	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
compared	NULL
with	NULL
those	NULL
in	NULL
uninfected	NULL
cells	NULL
,	NULL
the	NULL
turnover	NULL
rates	NULL
were	NULL
consistently	NULL
higher	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
(	NULL
compare	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
panels	NULL
)	NULL
.	NULL

These	NULL
data	NULL
were	NULL
all	NULL
normalized	NULL
to	NULL
the	NULL
B-actin	NULL
protein	NULL
levels	NULL
to	NULL
ensure	NULL
that	NULL
overall	NULL
protein	NULL
degradation	NULL
rates	NULL
were	NULL
not	NULL
affected	NULL
in	NULL
the	NULL
different	NULL
extract	NULL
preparations	NULL
.	NULL

In	NULL
HIV-1-infected	NULL
cells	NULL
,	NULL
immunoblot	NULL
analysis	NULL
of	NULL
IxBa	NULL
levels	NULL
demonstrated	NULL
that	NULL
the	NULL
total	NULL
pool	NULL
of	NULL
IxBa	NULL
turned	NULL
over	NULL
with	NULL
a	NULL
half-life	NULL
of	NULL
about	NULL
95	NULL
min	NULL
in	NULL
cycloheximide-treated	NULL
cells	NULL
,	NULL
whereas	NULL
in	NULL
uninfected	NULL
cells	NULL
the	NULL
t	NULL
,	NULL
,	NULL
,	NULL
of	NULL
IxBa	NULL
was	NULL
about	NULL
165	NULL
min	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
for	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
;	NULL
plotted	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

PMA-plus-cycloheximide	NULL
treatment	NULL
reduced	NULL
the	NULL
half-life	NULL
of	NULL
IxBa	NULL
in	NULL
PLB985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
to	NULL
100	NULL
and	NULL
50	NULL
min	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
12	NULL
;	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
both	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
with	NULL
TNF-	NULL
«	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
resulted	NULL
in	NULL
rapid	NULL
inducer-mediated	NULL
degradation	NULL
of	NULL
IxBa	NULL
with	NULL
a	NULL
t1	NULL
,	NULL
,	NULL
of	NULL
<	NULL
10	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
13	NULL
to	NULL
18	NULL
;	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
30-kDa	NULL
AR2Z0	NULL
immunoreactive	NULL
band	NULL
exhibiting	NULL
degradation	NULL
kinetics	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
IxBa	NULL
was	NULL
present	NULL
in	NULL
PLB-985	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

The	NULL
30-kDa	NULL
form	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
degradation	NULL
product	NULL
of	NULL
IxBa	NULL
,	NULL
although	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
of	NULL
a	NULL
differentially	NULL
spliced	NULL
product	NULL
or	NULL
a	NULL
distinct	NULL
immunoreactive	NULL
species	NULL
.	NULL

Similar	NULL
turnover	NULL
kinetics	NULL
for	NULL
IxBa	NULL
in	NULL
U937	NULL
cells	NULL
and	NULL
HIV-1-infected	NULL
cells	NULL
were	NULL
also	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
,	NULL
IxBa	NULL
had	NULL
half-lives	NULL
of	NULL
approximately	NULL
120	NULL
and	NULL
80	NULL
minutes	NULL
in	NULL
U937	NULL
cells	NULL
and	NULL
U9-IIIB	NULL
cells	NULL
,	NULL
respectively	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
for	NULL
U937	NULL
and	NULL
UYQ-IIIB	NULL
;	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

As	NULL
seen	NULL
with	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
,	NULL
TNF-	NULL
«	NULL
reduced	NULL
the	NULL
turnover	NULL
rate	NULL
to	NULL
<	NULL
10	NULL
min	NULL
for	NULL
both	NULL
cell	NULL
types	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
12	NULL
;	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
anti-IFN	NULL
antibody	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
for	NULL
48	NULL
h	NULL
altered	NULL
the	NULL
kinetics	NULL
of	NULL
IxBa	NULL
turnover	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
of	NULL
IxBa	NULL
levels	NULL
demonstrated	NULL
that	NULL
the	NULL
total	NULL
pool	NULL
of	NULL
IxBa	NULL
degraded	NULL
with	NULL
a	NULL
half-life	NULL
of	NULL
about	NULL
90	NULL
min	NULL
in	NULL
cycloheximide-treated	NULL
PLB-IIIB	NULL
cells	NULL
,	NULL
whereas	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
treated	NULL
with	NULL
anti-IFN	NULL
antibody	NULL
,	NULL
the	NULL
t	NULL
,	NULL
,	NULL
,	NULL
of	NULL
IxBa	NULL
was	NULL
about	NULL
160	NULL
min	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
turnover	NULL
rate	NULL
in	NULL
uninfected	NULL
PLB-985	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
constitutive	NULL
PKR	NULL
activity	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
overall	NULL
turnover	NULL
of	NULL
the	NULL
IxBa	NULL
pool	NULL
and	NULL
that	NULL
downregulation	NULL
of	NULL
PKR	NULL
by	NULL
interfering	NULL
with	NULL
the	NULL
IFN-inductive	NULL
signal	NULL
may	NULL
alter	NULL
IxBa	NULL
turnover	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

IxBa	NULL
mRNA	NULL
expression	NULL
in	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

We	NULL
next	NULL
sought	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
increased	NULL
turnover	NULL
rate	NULL
of	NULL
IxBa	NULL
in	NULL
HIV-infected	NULL
cells	NULL
was	NULL
accompanied	NULL
by	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
IB	NULL
gene	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
.	NULL

IxBa	NULL
mRNA	NULL
expression	NULL
was	NULL
examined	NULL
by	NULL
Northern	NULL
blot	NULL
analyses	NULL
and	NULL
normalized	NULL
to	NULL
actin	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

IxBa	NULL
(	NULL
MAD-3	NULL
)	NULL
mRNA	NULL
levels	NULL
were	NULL
equivalent	NULL
in	NULL
unstimulated	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
normalized	NULL
to	NULL
actin	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
and	NULL
6	NULL
and	NULL
7	NULL
)	NULL
and	NULL
were	NULL
inducible	NULL
by	NULL
PMA	NULL
treatment	NULL
or	NULL
Sendai	NULL
virus	NULL
infection	NULL
by	NULL
approximately	NULL
25-fold	NULL
in	NULL
PLB-985	NULL
and	NULL
by	NULL
5-	NULL
to	NULL
15-fold	NULL
in	NULL
PLB-IIIB	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
5	NULL
and	NULL
8	NULL
to	NULL
10	NULL
)	NULL
.	NULL

In	NULL
other	NULL
exper-	NULL
voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
REGULATION	NULL
IN	NULL
HIV-1-INFECTED	NULL
MYELOID	NULL
CELLS	NULL
5187	NULL
A	NULL
PLB985	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
IcBot	NULL
-mm	NULL
_-3OkD-mm-	NULL
-	NULL
«	NULL
*	NULL
sme	NULL
son	NULL
os	NULL
wass	NULL
me	NULL
o	NULL
=	NULL
--	NULL
PLBIIIB	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
Meee	NULL
Sore	NULL
vasu	NULL
deters	NULL
Isic	NULL
omar	NULL
IkBo	NULL
:	NULL
-	NULL
»	NULL
»	NULL
we	NULL
gee	NULL
Aum	NULL
:	NULL
ome	NULL
A	NULL
coms	NULL
coum	NULL
dumm	NULL
cums	NULL
«	NULL
mm	NULL
~-	NULL
cuse	NULL
:	NULL
#	NULL
©	NULL
*	NULL
``	NULL
Time	NULL
0	NULL
15	NULL
30	NULL
60	NULL
120	NULL
240	NULL
0	NULL
5	NULL
15	NULL
30	NULL
60	NULL
120	NULL
0	NULL
15	NULL
30	NULL
60	NULL
120	NULL
240	NULL
Unstimulated	NULL
+	NULL
PMA	NULL
+TNF	NULL
B	NULL
1000	NULL
HalfLife	NULL
(	NULL
minutes	NULL
)	NULL
100	NULL
o	NULL
PLB985	NULL
165	NULL
Relative	NULL
o	NULL
PLBIIB	NULL
96	NULL
Concentration	NULL
10	NULL
4	NULL
m	NULL
PLB985	NULL
+P	NULL
103	NULL
@	NULL
PLBIIIB	NULL
+P	NULL
48	NULL
&	NULL
PLB985	NULL
+T	NULL
<	NULL
15	NULL
4	NULL
PLBIIIB	NULL
+T	NULL
<	NULL
15	NULL
0	NULL
100	NULL
200	NULL
300	NULL
Time	NULL
(	NULL
minutes	NULL
)	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

IxBa	NULL
turnover	NULL
in	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
and	NULL
were	NULL
either	NULL
untreated	NULL
,	NULL
PMA	NULL
treated	NULL
,	NULL
or	NULL
TNF-a	NULL
treated	NULL
for	NULL
the	NULL
times	NULL
(	NULL
in	NULL
minutes	NULL
)	NULL
indicated	NULL
.	NULL

Protein	NULL
extracts	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
visualized	NULL
with	NULL
affinity-purified	NULL
IxBa	NULL
antibody	NULL
(	NULL
AR20	NULL
)	NULL
.	NULL

The	NULL
band	NULL
corresponding	NULL
to	NULL
IxBa	NULL
is	NULL
identified	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Autoradiograms	NULL
were	NULL
scanned	NULL
by	NULL
laser	NULL
densitometry	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
each	NULL
band	NULL
is	NULL
presented	NULL
in	NULL
terms	NULL
of	NULL
the	NULL
percentage	NULL
of	NULL
IxBa	NULL
remaining	NULL
in	NULL
cells	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
either	NULL
PMA	NULL
(	NULL
P	NULL
)	NULL
or	NULL
TNF-	NULL
«	NULL
(	NULL
T	NULL
)	NULL
compared	NULL
with	NULL
the	NULL
total	NULL
IxBa	NULL
at	NULL
time	NULL
zero	NULL
.	NULL

iments	NULL
,	NULL
IxBa	NULL
mRNA	NULL
levels	NULL
were	NULL
maximally	NULL
stimulated	NULL
2	NULL
h	NULL
after	NULL
treatment	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
,	NULL
and	NULL
by	NULL
24	NULL
h	NULL
after	NULL
induction	NULL
,	NULL
IxBa	NULL
mRNA	NULL
levels	NULL
were	NULL
the	NULL
same	NULL
as	NULL
those	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
response	NULL
to	NULL
increased	NULL
NF-kB	NULL
binding	NULL
activity	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
,	NULL
the	NULL
IxBa/MAD-3	NULL
gene	NULL
was	NULL
transcriptionally	NULL
induced	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
,	NULL
although	NULL
with	NULL
different	NULL
kinetic	NULL
profiles	NULL
.	NULL

Also	NULL
,	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
,	NULL
induction	NULL
of	NULL
IxBa	NULL
transcription	NULL
appears	NULL
to	NULL
be	NULL
decreased	NULL
in	NULL
response	NULL
to	NULL
various	NULL
stimuli	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

This	NULL
modulation	NULL
in	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
induction	NULL
may	NULL
reflect	NULL
differences	NULL
in	NULL
the	NULL
relative	NULL
abundance	NULL
and	NULL
transactivation	NULL
potential	NULL
of	NULL
the	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
HIV-1	NULL
infected	NULL
cells	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
IxBa	NULL
«	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
comparative	NULL
degree	NULL
of	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
in	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
,	NULL
IxBa	NULL
was	NULL
analyzed	NULL
at	NULL
different	NULL
times	NULL
following	NULL
treatment	NULL
with	NULL
TNF-a	NULL
or	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Phosphorylated	NULL
IxBa	NULL
was	NULL
detected	NULL
by	NULL
immunoblot	NULL
analysis	NULL
in	NULL
both	NULL
PLB-985	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
treated	NULL
with	NULL
TNF-a	NULL
as	NULL
early	NULL
as	NULL
1	NULL
or	NULL
2	NULL
min	NULL
after	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

The	NULL
more	NULL
slowly	NULL
migrating	NULL
band	NULL
,	NULL
present	NULL
only	NULL
in	NULL
TNF-	NULL
«	NULL
-stimulated	NULL
cells	NULL
,	NULL
was	NULL
lost	NULL
when	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
potato	NULL
acid	NULL
phosphatase	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
and	NULL
was	NULL
restored	NULL
when	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
phosphatase	NULL
and	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
thus	NULL
confirming	NULL
that	NULL
the	NULL
upper	NULL
band	NULL
represents	NULL
a	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
.	NULL

PMA	NULL
treatment	NULL
for	NULL
4	NULL
min	NULL
did	NULL
not	NULL
result	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
phosphorylated	NULL
IxBa	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
compare	NULL
lanes	NULL
4	NULL
and	NULL
2	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
TNF-a	NULL
is	NULL
a	NULL
more	NULL
potent	NULL
inducer	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
than	NULL
is	NULL
PMA	NULL
.	NULL

This	NULL
observa-	NULL
5188	NULL
DELUCA	NULL
ET	NULL
AL	NULL
.	NULL

U937	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
wow	NULL
woe	NULL
Nene	NULL
ol	NULL
mee	NULL
meas	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
%	NULL
IKBop	NULL
-pe	NULL
4	NULL
see	NULL
eee	NULL
ee	NULL
f	NULL
a	NULL
``	NULL
|	NULL
.s	NULL
USIIIB	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
seee	NULL
cee	NULL
cee	NULL
nom	NULL
uze	NULL
ons	NULL
sue	NULL
muse	NULL
muss	NULL
w	NULL
suena	NULL
wad	NULL
IxBot	NULL
-m	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
15	NULL
30	NULL
60	NULL
120	NULL
240	NULL
-	NULL
0	NULL
15	NULL
30	NULL
60	NULL
120	NULL
240	NULL
Unstimulated	NULL
+	NULL
TNFa	NULL
.	NULL

B	NULL
1000	NULL
100	NULL
10	NULL
4	NULL
T	NULL
'	NULL
T	NULL
0	NULL
100	NULL
200	NULL
300	NULL
Time	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

IxBa	NULL
turnover	NULL
in	NULL
U937	NULL
and	NULL
UY-IIIB	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
U937	NULL
and	NULL
U9-IIIB	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
and	NULL
were	NULL
either	NULL
untreated	NULL
or	NULL
TNF-a	NULL
treated	NULL
for	NULL
the	NULL
times	NULL
(	NULL
in	NULL
minutes	NULL
)	NULL
indicated	NULL
.	NULL

Protein	NULL
extracts	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
visualized	NULL
with	NULL
affinity-purified	NULL
IxBa	NULL
antibody	NULL
(	NULL
AR20	NULL
)	NULL
.	NULL

The	NULL
band	NULL
corresponding	NULL
to	NULL
IxBa	NULL
is	NULL
identified	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Autoradiograms	NULL
were	NULL
scanned	NULL
by	NULL
laser	NULL
densitometry	NULL
,	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
each	NULL
band	NULL
is	NULL
presented	NULL
in	NULL
terms	NULL
of	NULL
the	NULL
percentage	NULL
of	NULL
IxBa	NULL
«	NULL
remaining	NULL
in	NULL
U937	NULL
(	NULL
¢	NULL
,	NULL
,	NULL
,	NULL
,	NULL
120	NULL
min	NULL
)	NULL
(	NULL
0	NULL
)	NULL
,	NULL
U937	NULL
plus	NULL
TNF-	NULL
«	NULL
(	NULL
,	NULL
,	NULL
,	NULL
,	NULL
<	NULL
10	NULL
min	NULL
)	NULL
(	NULL
@	NULL
,	NULL
U9-IIB	NULL
(	NULL
¢	NULL
;	NULL
)	NULL
;	NULL
,	NULL
80	NULL
min	NULL
)	NULL
(	NULL
0	NULL
)	NULL
,	NULL
and	NULL
U9-IIIB	NULL
plus	NULL
TNF-a	NULL
(	NULL
¢	NULL
,	NULL
,	NULL
<	NULL
10	NULL
min	NULL
)	NULL
(	NULL
@	NULL
)	NULL
cells	NULL
compared	NULL
with	NULL
the	NULL
total	NULL
percentage	NULL
at	NULL
time	NULL
zero	NULL
.	NULL

tion	NULL
is	NULL
also	NULL
consistent	NULL
with	NULL
the	NULL
limited	NULL
effect	NULL
of	NULL
PMA	NULL
on	NULL
IxBa	NULL
turnover	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Constitutive	NULL
turnover	NULL
of	NULL
IxBa	NULL
protein	NULL
was	NULL
increased	NULL
in	NULL
PLBIIIB	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
PLB-985	NULL
cells	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
this	NULL
increase	NULL
was	NULL
related	NULL
to	NULL
an	NULL
enhanced	NULL
constitutive	NULL
phosphorylation	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
,	NULL
the	NULL
rate	NULL
of	NULL
accumulation	NULL
of	NULL
phosphorylated	NULL
IxBa	NULL
was	NULL
analyzed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

By	NULL
this	NULL
approach	NULL
,	NULL
IxBa	NULL
phosphorylation	NULL
in	NULL
PLB-985	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
)	NULL
and	NULL
PLB-IIIB	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
lanes	NULL
8	NULL
to	NULL
13	NULL
)	NULL
appeared	NULL
to	NULL
be	NULL
similar	NULL
.	NULL

Also	NULL
,	NULL
extracts	NULL
from	NULL
PLB-985	NULL
or	NULL
PLB-IIIB	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

8B	NULL
,	NULL
lanes	NULL
7	NULL
or	NULL
14	NULL
)	NULL
incubated	NULL
with	NULL
DMSO	NULL
for	NULL
2	NULL
h	NULL
resembled	NULL
control	NULL
extracts	NULL
,	NULL
confirming	NULL
that	NULL
accumulation	NULL
of	NULL
phosphorylated	NULL
IxBa	NULL
was	NULL
not	NULL
due	NULL
to	NULL
DMSO	NULL
treatment	NULL
but	NULL
rather	NULL
to	NULL
stabilization	NULL
of	NULL
the	NULL
phosphorylated	NULL
product	NULL
by	NULL
MG132	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
30-kDa	NULL
IxBa-like	NULL
band	NULL
specific	NULL
to	NULL
PLB-985	NULL
was	NULL
phosphorylated	NULL
at	NULL
time	NULL
zero	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
lane	NULL
1	NULL
,	NULL
lower	NULL
band	NULL
)	NULL
;	NULL
at	NULL
later	NULL
times	NULL
,	NULL
two	NULL
distinct	NULL
slowly	NULL
migrating	NULL
forms	NULL
of	NULL
30-kDa	NULL
IxBa	NULL
were	NULL
detectable	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

protein	NULL
expression	NULL
in	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

The	NULL
altered	NULL
kinetics	NULL
of	NULL
IxBa	NULL
turnover	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
suggested	NULL
that	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
may	NULL
be	NULL
similarly	NULL
altered	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
.	NULL

In	NULL
previous	NULL
studies	NULL
the	NULL
composition	NULL
of	NULL
NF-	NULL
«	NULL
B-DNA	NULL
complexes	NULL
was	NULL
analyzed	NULL
(	NULL
50	NULL
,	NULL
52	NULL
)	NULL
,	NULL
but	NULL
the	NULL
relative	NULL
abundance	NULL
of	NULL
different	NULL
NF-kB	NULL
subunits	NULL
was	NULL
not	NULL
evaluated	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
protein	NULL
levels	NULL
of	NULL
various	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
proteins	NULL
in	NULL
HIV-1-infected	NULL
and	NULL
control	NULL
PLB-985	NULL
cells	NULL
,	NULL
immunoblot	NULL
analyses	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
subunit-specific	NULL
antibodies	NULL
were	NULL
performed	NULL
and	NULL
normalized	NULL
by	NULL
analysis	NULL
of	NULL
B-actin	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Protein	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
induced	NULL
for	NULL
8	NULL
,	NULL
16	NULL
,	NULL
or	NULL
22	NULL
h	NULL
with	NULL
PMA	NULL
or	NULL
TNF-	NULL
«	NULL
.	NULL

A	NULL
representative	NULL
summary	NULL
of	NULL
the	NULL
immunoblot	NULL
analyses	NULL
of	NULL
NF-kB1	NULL
and	NULL
NF-	NULL
«	NULL
kB2	NULL
proteins	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
and	NULL
illustrates	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
NF-kB2	NULL
p100	NULL
and	NULL
p52	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
and	NULL
B	NULL
)	NULL
were	NULL
higher	NULL
in	NULL
unstimulated	NULL
PLB-IIIB	NULL
cells	NULL
than	NULL
in	NULL
unstimulated	NULL
PLB-985	NULL
cells	NULL
.	NULL

HIV-1-infected	NULL
cells	NULL
had	NULL
approximately	NULL
three-	NULL
to	NULL
fourfold	NULL
more	NULL
p100	NULL
and	NULL
twofold	NULL
more	NULL
pS2	NULL
than	NULL
uninfected	NULL
PLB-985	NULL
cells	NULL
.	NULL

NF-	NULL
«	NULL
B1	NULL
p105	NULL
and	NULL
p50	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
and	NULL
D	NULL
)	NULL
were	NULL
not	NULL
significantly	NULL
increased	NULL
.	NULL

Stimulation	NULL
with	NULL
PMA	NULL
or	NULL
TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
NF-	NULL
«	NULL
xB1	NULL
p105	NULL
and	NULL
p50	NULL
levels	NULL
but	NULL
resulted	NULL
in	NULL
enhanced	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
xB2	NULL
p100	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
.	NULL

RelA	NULL
(	NULL
p65	NULL
)	NULL
levels	NULL
were	NULL
about	NULL
100	NULL
t/	NULL
,	NULL
=160	NULL
minutes	NULL
50	NULL
Relative	NULL
Concentration	NULL
t1/2	NULL
=	NULL
90	NULL
minutes	NULL
0	NULL
100	NULL
200	NULL
300	NULL
400	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

IxBa	NULL
turnover	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
treated	NULL
with	NULL
anti-IFN	NULL
antibody	NULL
.	NULL

PLB-IIIB	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
anti-IFN	NULL
antibody	NULL
at	NULL
1,000	NULL
IU/ml	NULL
for	NULL
48	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
for	NULL
different	NULL
times	NULL
,	NULL
protein	NULL
extracts	NULL
(	NULL
20	NULL
mg	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
visualized	NULL
with	NULL
affinity-purified	NULL
IxBa	NULL
«	NULL
antibody	NULL
(	NULL
AR20	NULL
)	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Autoradiograms	NULL
were	NULL
scanned	NULL
by	NULL
laser	NULL
densitometry	NULL
,	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
IxBa	NULL
remaining	NULL
at	NULL
different	NULL
times	NULL
after	NULL
the	NULL
cycloheximide	NULL
addition	NULL
is	NULL
presented	NULL
as	NULL
percentage	NULL
of	NULL
IxBa	NULL
remaining	NULL
in	NULL
untreated	NULL
PLB-IIIB	NULL
cells	NULL
(	NULL
0	NULL
)	NULL
or	NULL
PLB-IIIB	NULL
cells	NULL
treated	NULL
with	NULL
anti-IFN	NULL
antibody	NULL
(	NULL
&	NULL
)	NULL
.	NULL

voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
1	NULL
20	NULL
8	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
MAD-3	NULL
--	NULL
«	NULL
©	NULL
=	NULL
Actin	NULL
--	NULL
w	NULL
Inducer	NULL
U	NULL
MP	NULL
OT	NULL
S	NULL
U	NULL
MOP	NULL
TS	NULL
Fold	NULL
1.0	NULL
1.4	NULL
28	NULL
27	NULL
24	NULL
0.9	NULL
1.1	NULL
7.0	NULL
5.0	NULL
15	NULL
Induction	NULL
PLB985	NULL
PLBIIIB	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
IxBa	NULL
«	NULL
(	NULL
MAD-3	NULL
)	NULL
mRNA	NULL
levels	NULL
in	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
PLB-985	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
and	NULL
PLB-IIIB	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
cells	NULL
that	NULL
were	NULL
untreated	NULL
(	NULL
U	NULL
)	NULL
,	NULL
mock	NULL
infected	NULL
(	NULL
M	NULL
)	NULL
,	NULL
PMA	NULL
treated	NULL
(	NULL
P	NULL
)	NULL
,	NULL
TNF-	NULL
«	NULL
(	NULL
T	NULL
)	NULL
treated	NULL
,	NULL
or	NULL
Sendai	NULL
virus	NULL
infected	NULL
(	NULL
$	NULL
)	NULL
for	NULL
6	NULL
h.	NULL
RNA	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
denaturing	NULL
agarose	NULL
gel	NULL
containing	NULL
ethidium	NULL
bromide	NULL
and	NULL
visualized	NULL
under	NULL
UV	NULL
light	NULL
(	NULL
310	NULL
nm	NULL
)	NULL
.	NULL

After	NULL
RNA	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
first	NULL
probed	NULL
with	NULL
an	NULL
IxBa	NULL
«	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
subsequently	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
an	NULL
actin	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
IxBa	NULL
RNA	NULL
transcript	NULL
MAD-3	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
and	NULL
the	NULL
actin	NULL
transcript	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
are	NULL
identified	NULL
by	NULL
arrows	NULL
.	NULL

The	NULL
fold	NULL
induction	NULL
after	NULL
normalization	NULL
to	NULL
the	NULL
actin	NULL
signal	NULL
is	NULL
indicated	NULL
below	NULL
each	NULL
lane	NULL
.	NULL

twofold	NULL
higher	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
than	NULL
in	NULL
PLB-985	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
levels	NULL
were	NULL
not	NULL
dramatically	NULL
altered	NULL
by	NULL
PMA	NULL
or	NULL
TNF-a	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

10C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
c-Rel	NULL
were	NULL
at	NULL
least	NULL
eightfold	NULL
higher	NULL
in	NULL
infected	NULL
cells	NULL
than	NULL
in	NULL
noninfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

10A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Following	NULL
induction	NULL
with	NULL
PMA	NULL
or	NULL
TNF-	NULL
«	NULL
,	NULL
c-Rel	NULL
levels	NULL
were	NULL
up	NULL
to	NULL
50-fold	NULL
higher	NULL
than	NULL
the	NULL
levels	NULL
detected	NULL
in	NULL
unstimulated	NULL
PLB-985	NULL
cells	NULL
and	NULL
2-	NULL
to	NULL
3-fold	NULL
higher	NULL
than	NULL
the	NULL
levels	NULL
of	NULL
c-Rel	NULL
protein	NULL
in	NULL
unstimulated	NULL
PLB-IIIB	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

10A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
stimulation	NULL
with	NULL
PMA	NULL
or	NULL
TNF-a	NULL
for	NULL
22	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

10B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
led	NULL
to	NULL
sustained	NULL
expression	NULL
of	NULL
c-Rel	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
,	NULL
whereas	NULL
in	NULL
PLB-985	NULL
cells	NULL
,	NULL
c-Rel	NULL
levels	NULL
returned	NULL
to	NULL
control	NULL
levels	NULL
.	NULL

Other	NULL
studies	NULL
also	NULL
demonstrated	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
expression	NULL
was	NULL
similarly	NULL
increased	NULL
in	NULL
U9-IIIB	NULL
cells	NULL
and	NULL
in	NULL
U937	NULL
cells	NULL
;	NULL
in	NULL
addition	NULL
,	NULL
U9-IIIB	NULL
cells	NULL
exhibited	NULL
increased	NULL
levels	NULL
of	NULL
p105	NULL
and	NULL
p50	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
intracellular	NULL
pools	NULL
of	NULL
NF-kB	NULL
subunits	NULL
are	NULL
increased	NULL
in	NULL
chronically	NULL
HIV-1-infected	NULL
myeloid	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
we	NULL
demonstrate	NULL
that	NULL
regulation	NULL
of	NULL
NF-kB/IkBa	NULL
expression	NULL
is	NULL
altered	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
as	NULL
a	NULL
result	NULL
of	NULL
chronic	NULL
HIV-1	NULL
infection	NULL
:	NULL
(	NULL
i	NULL
)	NULL
constitutive	NULL
expression	NULL
of	NULL
IFN	NULL
mRNA	NULL
and	NULL
altered	NULL
kinetics	NULL
of	NULL
IFN	NULL
mRNA	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
Sendai	NULL
virus	NULL
infection	NULL
were	NULL
demonstrated	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
compared	NULL
with	NULL
those	NULL
in	NULL
PLB-985	NULL
cells	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
PKR	NULL
protein	NULL
and	NULL
enzymatic	NULL
activity	NULL
were	NULL
increased	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
;	NULL
(	NULL
iii	NULL
)	NULL
IxBa	NULL
turnover	NULL
was	NULL
increased	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
uninfected	NULL
PLB-985	NULL
cells	NULL
,	NULL
in	NULL
part	NULL
because	NULL
of	NULL
PKR	NULL
activity	NULL
;	NULL
and	NULL
(	NULL
iv	NULL
)	NULL
increased	NULL
levels	NULL
of	NULL
c-Rel	NULL
and	NULL
p100/pS52	NULL
proteins	NULL
were	NULL
de	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
REGULATION	NULL
IN	NULL
HIV-1-INFECTED	NULL
MYELOID	NULL
CELLS	NULL
5189	NULL
tected	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
compared	NULL
with	NULL
those	NULL
in	NULL
PLB-985	NULL
cells	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
anti-IFN-	NULL
«	NULL
/B	NULL
antibody	NULL
to	NULL
the	NULL
culture	NULL
dramatically	NULL
reduced	NULL
the	NULL
level	NULL
of	NULL
PKR	NULL
expression	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
,	NULL
thus	NULL
demonstrating	NULL
a	NULL
role	NULL
for	NULL
low-level	NULL
IFN	NULL
production	NULL
in	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
PKR	NULL
.	NULL

As	NULL
demonstrated	NULL
previously	NULL
,	NULL
PKR	NULL
is	NULL
capable	NULL
of	NULL
phosphorylating	NULL
IxBa	NULL
in	NULL
vitro	NULL
and	NULL
inducing	NULL
NF-kB-binding	NULL
activity	NULL
(	NULL
27	NULL
,	NULL
30	NULL
)	NULL
.	NULL

The	NULL
persistent	NULL
inductive	NULL
signal	NULL
provided	NULL
by	NULL
PKR	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
constitutive	NULL
NF-	NULL
«	NULL
kB-binding	NULL
activity	NULL
observed	NULL
in	NULL
HIV-1-infected	NULL
myeloid	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
selective	NULL
increase	NULL
in	NULL
NF-kB	NULL
subunits	NULL
,	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
appears	NULL
to	NULL
ultimately	NULL
increase	NULL
the	NULL
intracellular	NULL
pool	NULL
of	NULL
NF-kB/IkBa	NULL
by	NULL
an	NULL
autoregulatory	NULL
mechanism	NULL
.	NULL

The	NULL
increased	NULL
pool	NULL
of	NULL
NF-	NULL
«	NULL
xB/IxBa	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
chronically	NULL
activated	NULL
state	NULL
of	NULL
HIV-1-infected	NULL
cells	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
addressed	NULL
the	NULL
mechanism	NULL
of	NULL
NF-kB	NULL
activation	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
.	NULL

Bachelerie	NULL
et	NULL
al	NULL
.	NULL

demonstrated	NULL
sustained	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
chronically	NULL
HIV-infected	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
(	NULL
2	NULL
)	NULL
;	NULL
furthermore	NULL
,	NULL
occupancy	NULL
of	NULL
the	NULL
viral	NULL
enhancer	NULL
by	NULL
NF-kB	NULL
(	NULL
pS0/p65	NULL
)	NULL
was	NULL
re	NULL
A	NULL
102	NULL
3	NULL
40	NULL
5006	NULL
P-IkBo	NULL
.	NULL

-	NULL
»	NULL
IxBo	NULL
.	NULL

__	NULL
-a	NULL
te	NULL
«	NULL
»	NULL
-	NULL
#	NULL
#	NULL
#	NULL
ons	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
4	NULL
2	NULL
4	NULL
10	NULL
1	NULL
Treatment	NULL
--	NULL
T	NULL
TOP	NULL
T	NULL
T	NULL
Phosphatase	NULL
|	NULL
-	NULL
-	NULL
-	NULL
>	NULL
+o	NULL
+	NULL
Phosphatase	NULL
|	NULL
L	NULL
L0	NULL
.	NULL

.	NULL

0	NULL
c.	NULL
£	NULL
Inhibitor	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1112	NULL
1314	NULL
P-IxBa	NULL
IxBao	NULL
.	NULL

-	NULL
--	NULL
»	NULL
se	NULL
m	NULL
w	NULL
re	NULL
can	NULL
:	NULL
cone	NULL
evel	NULL
eh	NULL
«	NULL
tn-ils	NULL
:	NULL
am	NULL
m	NULL
«	NULL
im	NULL
*+	NULL
r	NULL
[	NULL
___	NULL
_puBsss	NULL
__	NULL
]	NULL
|	NULL
PLB	NULL
IIIB	NULL
Time	NULL
(	NULL
mm	NULL
)	NULL
0	NULL
10	NULL
20	NULL
30	NULL
60120120	NULL
0	NULL
10	NULL
20	NULL
30	NULL
60120120	NULL
MG132	NULL
=	NULL
+0	NULL
+	NULL
b	NULL
#	NULL
¢	NULL
o=	NULL
so	NULL
#	NULL
k	NULL
&	NULL
#	NULL
#	NULL
o=	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Analysis	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
PLB-IIIB	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
(	NULL
T	NULL
)	NULL
for	NULL
1	NULL
or	NULL
2	NULL
min	NULL
(	NULL
lanes	NULL
2	NULL
or	NULL
3	NULL
,	NULL
respectively	NULL
)	NULL
or	NULL
PMA	NULL
(	NULL
P	NULL
)	NULL
for	NULL
4	NULL
min	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
-treated	NULL
samples	NULL
(	NULL
1	NULL
min	NULL
)	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
potato	NULL
acid	NULL
phosphatase	NULL
treatment	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
potato	NULL
acid	NULL
phosphatase	NULL
treatment	NULL
plus	NULL
inhibitors	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
visualized	NULL
with	NULL
affinity-purified	NULL
IxBa	NULL
antibody	NULL
(	NULL
AR20	NULL
)	NULL
.	NULL

TNF-	NULL
«	NULL
-induced	NULL
phosphorylation	NULL
was	NULL
compared	NULL
with	NULL
control	NULL
levels	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
accumulation	NULL
of	NULL
phosphorylated	NULL
IxBa	NULL
(	NULL
P-IxBa	NULL
)	NULL
was	NULL
analyzed	NULL
in	NULL
PLB-985	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
7	NULL
)	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
(	NULL
lanes	NULL
8	NULL
to	NULL
14	NULL
)	NULL
incubated	NULL
with	NULL
25	NULL
wM	NULL
MG132	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
6	NULL
and	NULL
9	NULL
to	NULL
13	NULL
)	NULL
or	NULL
DMSO	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
14	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

IxBa	NULL
,	NULL
P-IxBa	NULL
,	NULL
and	NULL
the	NULL
30-kDa	NULL
band	NULL
,	NULL
detected	NULL
with	NULL
a	NULL
monoclonal	NULL
IxBa	NULL
antibody	NULL
,	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

5190	NULL
DELUCA	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

Relative	NULL
Concentration	NULL
PLB985	NULL
PLBIIIB	NULL
PLB985	NULL
PLBIIIB	NULL
22	NULL
hrs	NULL
8	NULL
hrs	NULL
C	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
-_-—-—i——	NULL
PLB985	NULL
PLBIIIB	NULL
PLB985	NULL
PLBIIIB	NULL
8	NULL
hrs	NULL
22	NULL
hrs	NULL
D	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Relative	NULL
Concentration	NULL
1	NULL
p50	NULL
PLB985	NULL
PLBIIIB	NULL
PLB985	NULL
PLBIIIB	NULL
8	NULL
hrs	NULL
22	NULL
hrs	NULL
PLB985	NULL
PLBIIIB	NULL
PLB985	NULL
PLBIIIB	NULL
8	NULL
hrs	NULL
22	NULL
hrs	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Analysis	NULL
of	NULL
NF-	NULL
«	NULL
B1	NULL
and	NULL
NF-xB2	NULL
protein	NULL
expression	NULL
in	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

Cell	NULL
extracts	NULL
isolated	NULL
by	NULL
detergent	NULL
lysis	NULL
from	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
left	NULL
untreated	NULL
(	NULL
0	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
PMA	NULL
for	NULL
8	NULL
or	NULL
22	NULL
h	NULL
(	NULL
RW	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
and	NULL
blotted	NULL
with	NULL
NF-	NULL
«	NULL
B-specific	NULL
antisera	NULL
:	NULL
p100	NULL
(	NULL
AR40	NULL
)	NULL
(	NULL
A	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
AR43	NULL
)	NULL
(	NULL
B	NULL
)	NULL
,	NULL
p105	NULL
(	NULL
AR27	NULL
)	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
p50	NULL
(	NULL
AR27	NULL
)	NULL
(	NULL
D	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
signals	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Autoradiograms	NULL
were	NULL
scanned	NULL
by	NULL
laser	NULL
densitometry	NULL
,	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
each	NULL
band	NULL
is	NULL
plotted	NULL
in	NULL
terms	NULL
of	NULL
relative	NULL
protein	NULL
levels	NULL
.	NULL

Because	NULL
of	NULL
affinity	NULL
differences	NULL
between	NULL
NF-xB	NULL
antibodies	NULL
,	NULL
the	NULL
relative	NULL
amounts	NULL
of	NULL
the	NULL
different	NULL
proteins	NULL
can	NULL
not	NULL
be	NULL
compared	NULL
.	NULL

quired	NULL
for	NULL
ongoing	NULL
transcription	NULL
of	NULL
integrated	NULL
HIV	NULL
provirus	NULL
in	NULL
monocytic	NULL
cells	NULL
chronically	NULL
infected	NULL
with	NULL
HIV-1	NULL
(	NULL
24a	NULL
)	NULL
.	NULL

Increased	NULL
transcription	NULL
and	NULL
processing	NULL
of	NULL
the	NULL
p105	NULL
precursor	NULL
may	NULL
be	NULL
one	NULL
mechanism	NULL
to	NULL
increase	NULL
intracellular	NULL
pools	NULL
of	NULL
NF-kB	NULL
in	NULL
chronically	NULL
infected	NULL
U937	NULL
cells	NULL
(	NULL
42	NULL
)	NULL
and	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
HIV	NULL
protease	NULL
which	NULL
cleaves	NULL
p105	NULL
to	NULL
generate	NULL
a	NULL
45-kDa	NULL
DNA-binding	NULL
subunit	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
HIV-infected	NULL
T	NULL
cells	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
also	NULL
found	NULL
elevated	NULL
expression	NULL
of	NULL
p105	NULL
protein	NULL
in	NULL
chronically	NULL
infected	NULL
U937	NULL
cells	NULL
,	NULL
significant	NULL
increases	NULL
in	NULL
p105	NULL
protein	NULL
were	NULL
not	NULL
seen	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

These	NULL
cells	NULL
,	NULL
although	NULL
both	NULL
myeloid	NULL
precursor	NULL
cells	NULL
,	NULL
differ	NULL
in	NULL
their	NULL
state	NULL
of	NULL
differentiation	NULL
,	NULL
suggesting	NULL
that	NULL
NF-kB	NULL
may	NULL
be	NULL
developmentally	NULL
regulated	NULL
.	NULL

HIV	NULL
infection	NULL
of	NULL
the	NULL
monocytic	NULL
THP-1	NULL
cell	NULL
line	NULL
resulted	NULL
in	NULL
two	NULL
populations	NULL
of	NULL
chronically	NULL
infected	NULL
cells	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Nuclear	NULL
ex	NULL
tracts	NULL
from	NULL
productively	NULL
infected	NULL
cells	NULL
contained	NULL
increased	NULL
p50-p65	NULL
heterodimer-binding	NULL
activity	NULL
,	NULL
whereas	NULL
extracts	NULL
from	NULL
cells	NULL
expressing	NULL
low	NULL
levels	NULL
of	NULL
virus	NULL
(	NULL
restricted	NULL
expression	NULL
)	NULL
displayed	NULL
only	NULL
p50	NULL
homodimer-binding	NULL
activity	NULL
.	NULL

In	NULL
another	NULL
study	NULL
,	NULL
increased	NULL
NF-kB	NULL
p50-p65-binding	NULL
activity	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
HIV-1-infected	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
and	NULL
macrophages	NULL
but	NULL
not	NULL
in	NULL
the	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
certain	NULL
level	NULL
of	NULL
myeloid	NULL
maturation	NULL
is	NULL
required	NULL
prior	NULL
to	NULL
NF-kB	NULL
induction	NULL
(	NULL
60	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
specific	NULL
lysosomal	NULL
proteases	NULL
expressed	NULL
in	NULL
my-elomonocytic	NULL
cells	NULL
,	NULL
including	NULL
primary	NULL
monocytes	NULL
,	NULL
HL-60	NULL
,	NULL
and	NULL
certain	NULL
clones	NULL
of	NULL
U937	NULL
and	NULL
THP-1	NULL
cells	NULL
,	NULL
resulted	NULL
in	NULL
carboxy-terminal	NULL
cleavage	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
.	NULL

The	NULL
generation	NULL
of	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
RelA	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
Rel-A	NULL
containing	NULL
protein-DNA	NULL
complexes	NULL
with	NULL
transcriptional	NULL
activity	NULL
that	NULL
re	NULL
voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
A.	NULL
c-Rel	NULL
B.	NULL
c-Rel	NULL
1	NULL
2	NULL
3	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
--	NULL
=	NULL
stone	NULL
ditt	NULL
~	NULL
60	NULL
7	NULL
50	NULL
4	NULL
40	NULL
4	NULL
Relative	NULL
Concentration	NULL
4	NULL
30	NULL
{	NULL
20	NULL
0|UT	NULL
PLB985	NULL
PLBIIIB	NULL
PLB985	NULL
_	NULL
PLBIIB	NULL
C.	NULL
RelA	NULL
D.	NULL
RelA	NULL
10	NULL
2	NULL
3	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
boos	NULL
cool..	NULL
@	NULL
i	NULL
cues	NULL
_..	NULL
cage	NULL
<	NULL
e	NULL
Relative	NULL
Concentration	NULL
PLBIIIB	NULL
PLB985	NULL
PLBIIIB	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

Analysis	NULL
of	NULL
c-Rel	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
expression	NULL
in	NULL
PLB-985	NULL
and	NULL
PLBIIB	NULL
cells	NULL
.	NULL

Cell	NULL
extracts	NULL
isolated	NULL
by	NULL
detergent	NULL
lysis	NULL
from	NULL
PLB-985	NULL
and	NULL
PLB-IIIB	NULL
cells	NULL
left	NULL
untreated	NULL
(	NULL
U	NULL
)	NULL
(	NULL
0	NULL
)	NULL
,	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
P	NULL
)	NULL
for	NULL
16	NULL
h	NULL
,	NULL
or	NULL
treated	NULL
with	NULL
TNF-a	NULL
(	NULL
T	NULL
)	NULL
for	NULL
22	NULL
h	NULL
(	NULL
WN	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
and	NULL
blotted	NULL
with	NULL
NF-	NULL
«	NULL
B-specific	NULL
antisera	NULL
:	NULL
c-Rel	NULL
with	NULL
and	NULL
without	NULL
PMA	NULL
(	NULL
AR22	NULL
)	NULL
(	NULL
A	NULL
)	NULL
,	NULL
c-Rel	NULL
with	NULL
and	NULL
without	NULL
TNF-	NULL
«	NULL
(	NULL
B	NULL
)	NULL
,	NULL
p65	NULL
with	NULL
and	NULL
without	NULL
PMA	NULL
(	NULL
AR28	NULL
)	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
p65	NULL
with	NULL
and	NULL
without	NULL
TNF-	NULL
«	NULL
(	NULL
AR28	NULL
)	NULL
(	NULL
D	NULL
)	NULL
.	NULL

sembled	NULL
NF-	NULL
«	NULL
kB1	NULL
p50	NULL
homodimers	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
lysosomal	NULL
proteases	NULL
was	NULL
decreased	NULL
after	NULL
cellular	NULL
exposure	NULL
to	NULL
agents	NULL
that	NULL
induced	NULL
monocytic	NULL
but	NULL
not	NULL
granulocytic	NULL
differentiation	NULL
.	NULL

Although	NULL
RelA	NULL
cleavage	NULL
was	NULL
thought	NULL
to	NULL
occur	NULL
only	NULL
during	NULL
cell	NULL
extract	NULL
preparation	NULL
in	NULL
vitro	NULL
,	NULL
this	NULL
enzymatic	NULL
activity	NULL
may	NULL
nonetheless	NULL
restrict	NULL
virus	NULL
expression	NULL
in	NULL
immature	NULL
myeloid	NULL
cells	NULL
in	NULL
vivo	NULL
,	NULL
by	NULL
a	NULL
mechanism	NULL
independent	NULL
of	NULL
transcription	NULL
,	NULL
thus	NULL
accounting	NULL
for	NULL
cell	NULL
populations	NULL
exhibiting	NULL
restricted	NULL
or	NULL
productive	NULL
patterns	NULL
of	NULL
HIV-1	NULL
replication	NULL
(	NULL
18	NULL
)	NULL
.	NULL

An	NULL
N-terminal	NULL
RelA-specific	NULL
antibody	NULL
was	NULL
used	NULL
to	NULL
examine	NULL
whether	NULL
PLB-IIIB	NULL
or	NULL
PLB-985	NULL
cells	NULL
contained	NULL
the	NULL
truncated	NULL
form	NULL
of	NULL
RelA	NULL
;	NULL
no	NULL
evidence	NULL
of	NULL
truncated	NULL
RelA	NULL
was	NULL
obtained	NULL
with	NULL
the	NULL
PLB-IIIB/	NULL
PLB-985	NULL
extracts	NULL
or	NULL
isolation	NULL
procedure	NULL
used	NULL
in	NULL
this	NULL
study	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Modulation	NULL
of	NULL
intracellular	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
levels	NULL
represents	NULL
a	NULL
control	NULL
mechanism	NULL
for	NULL
enhanced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
xB-regu-lated	NULL
gene	NULL
expression	NULL
.	NULL

Enhanced	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
xB2	NULL
and	NULL
c-Rel	NULL
in	NULL
PLB-IIIB	NULL
(	NULL
and	NULL
NF-kB2	NULL
,	NULL
NF-kB1	NULL
,	NULL
and	NULL
c-Rel	NULL
in	NULL
U9-IIIB	NULL
)	NULL
cells	NULL
may	NULL
result	NULL
in	NULL
increased	NULL
intracellular	NULL
pools	NULL
of	NULL
latent	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

c-Rel	NULL
expression	NULL
was	NULL
particularly	NULL
augmented	NULL
in	NULL
HIV-infected	NULL
cells	NULL
and	NULL
exhibited	NULL
increased	NULL
responsiveness	NULL
to	NULL
PMA	NULL
and	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
REGULATION	NULL
IN	NULL
HIV-1-INFECTED	NULL
MYELOID	NULL
CELLS	NULL
5191	NULL
TNF-a	NULL
stimulation	NULL
.	NULL

We	NULL
previously	NULL
reported	NULL
the	NULL
appearance	NULL
of	NULL
an	NULL
unidentified	NULL
90-	NULL
to	NULL
100-kDa	NULL
protein	NULL
upon	NULL
HIV	NULL
infection	NULL
of	NULL
PLB-985	NULL
cells	NULL
.	NULL

This	NULL
protein	NULL
bound	NULL
the	NULL
IFN-B	NULL
PRDII	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
with	NULL
high	NULL
affinity	NULL
(	NULL
50-52	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
HIV-1	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
.	NULL

Given	NULL
the	NULL
dramatic	NULL
increase	NULL
in	NULL
c-Rel	NULL
activity	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
c-Rel	NULL
in	NULL
response	NULL
to	NULL
TNF-	NULL
«	NULL
and	NULL
PMA	NULL
stimulation	NULL
,	NULL
these	NULL
results	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
90-kDa	NULL
protein	NULL
is	NULL
in	NULL
fact	NULL
c-Rel	NULL
(	NULL
50-52	NULL
)	NULL
.	NULL

The	NULL
rel4	NULL
(	NULL
p65	NULL
)	NULL
gene	NULL
is	NULL
not	NULL
known	NULL
to	NULL
be	NULL
stimulated	NULL
in	NULL
response	NULL
to	NULL
mitogenic	NULL
stimuli	NULL
,	NULL
including	NULL
PMA	NULL
(	NULL
56	NULL
)	NULL
,	NULL
and	NULL
is	NULL
not	NULL
regulated	NULL
by	NULL
NF-kB	NULL
(	NULL
62	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
previous	NULL
observations	NULL
,	NULL
since	NULL
the	NULL
levels	NULL
of	NULL
p65	NULL
were	NULL
only	NULL
moderately	NULL
increased	NULL
in	NULL
the	NULL
differentiated	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

Increasing	NULL
the	NULL
intracellular	NULL
levels	NULL
of	NULL
distinct	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
would	NULL
permit	NULL
high	NULL
levels	NULL
of	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat-directed	NULL
gene	NULL
transcription	NULL
and	NULL
would	NULL
thus	NULL
provide	NULL
an	NULL
environment	NULL
for	NULL
continued	NULL
HIV	NULL
replication	NULL
(	NULL
24a	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
changing	NULL
the	NULL
relative	NULL
abundance	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
would	NULL
also	NULL
be	NULL
expected	NULL
to	NULL
alter	NULL
host	NULL
transcription	NULL
since	NULL
several	NULL
studies	NULL
have	NULL
delineated	NULL
differential	NULL
transcriptional	NULL
specificities	NULL
of	NULL
NF-kB	NULL
homo-	NULL
and	NULL
het-erodimer	NULL
combinations	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
53	NULL
)	NULL
.	NULL

IxBa	NULL
phosphorylation	NULL
and	NULL
turnover	NULL
.	NULL

The	NULL
level	NULL
of	NULL
IxBa	NULL
protein	NULL
was	NULL
consistently	NULL
lower	NULL
in	NULL
PLB-985	NULL
cells	NULL
than	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
pool	NULL
of	NULL
IxBa	NULL
«	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
exhibited	NULL
a	NULL
higher	NULL
rate	NULL
of	NULL
protein	NULL
turnover	NULL
.	NULL

Increased	NULL
IxBa	NULL
protein	NULL
turnover	NULL
has	NULL
been	NULL
documented	NULL
in	NULL
other	NULL
HIV-1-infected	NULL
myeloid	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
31	NULL
)	NULL
,	NULL
suggesting	NULL
one	NULL
mechanism	NULL
for	NULL
increased	NULL
constitutive	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Using	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
,	NULL
we	NULL
demonstrated	NULL
the	NULL
accumulation	NULL
of	NULL
phosphorylated	NULL
forms	NULL
of	NULL
IxBa	NULL
in	NULL
both	NULL
uninfected	NULL
and	NULL
HIV-1-infected	NULL
cells	NULL
,	NULL
although	NULL
only	NULL
minor	NULL
differences	NULL
in	NULL
the	NULL
rates	NULL
of	NULL
accumulation	NULL
were	NULL
detected	NULL
.	NULL

McEI-hinny	NULL
et	NULL
al	NULL
.	NULL

also	NULL
suggested	NULL
that	NULL
the	NULL
increased	NULL
turnover	NULL
compensated	NULL
for	NULL
the	NULL
elevated	NULL
levels	NULL
of	NULL
IxBa	NULL
protein	NULL
seen	NULL
in	NULL
chronically	NULL
HIV-1-infected	NULL
U937	NULL
cells	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Increased	NULL
IxBa	NULL
synthesis	NULL
and	NULL
turnover	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
elevated	NULL
levels	NULL
of	NULL
p100/	NULL
p52	NULL
and	NULL
c-Rel	NULL
,	NULL
indicate	NULL
a	NULL
specific	NULL
upregulation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/	NULL
IxBa	NULL
autoregulatory	NULL
loop	NULL
in	NULL
HIV-1-infected	NULL
myeloid	NULL
cells	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
IxBa	NULL
mRNA	NULL
induction	NULL
is	NULL
decreased	NULL
in	NULL
PLBIIIB	NULL
cells	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
differential	NULL
responsiveness	NULL
of	NULL
the	NULL
IxBa	NULL
promoter	NULL
to	NULL
NF-kB	NULL
activation	NULL
.	NULL

The	NULL
IxBa	NULL
promoter	NULL
is	NULL
transcriptionally	NULL
activated	NULL
by	NULL
the	NULL
NF-kB	NULL
subunits	NULL
RelA	NULL
and	NULL
p50	NULL
but	NULL
to	NULL
only	NULL
a	NULL
limited	NULL
extent	NULL
by	NULL
c-Rel	NULL
(	NULL
28	NULL
)	NULL
.	NULL

While	NULL
the	NULL
levels	NULL
of	NULL
RelA	NULL
are	NULL
not	NULL
significantly	NULL
elevated	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
,	NULL
c-Rel	NULL
and	NULL
p100/p52	NULL
account	NULL
for	NULL
a	NULL
much	NULL
greater	NULL
proportion	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pool	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
30-kDa	NULL
IxB-like	NULL
band	NULL
specific	NULL
to	NULL
PLB-985	NULL
cells	NULL
degraded	NULL
with	NULL
kinetics	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
IxBa	NULL
and	NULL
exhibited	NULL
a	NULL
similar	NULL
pattern	NULL
of	NULL
accumulation	NULL
of	NULL
phosphorylated	NULL
forms	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
MG132	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
30-kDa	NULL
protein	NULL
accumulated	NULL
two	NULL
distinct	NULL
phosphorylated	NULL
species	NULL
with	NULL
time	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
.	NULL

The	NULL
characteristics	NULL
of	NULL
this	NULL
species	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
degradation	NULL
product	NULL
of	NULL
IxBa	NULL
,	NULL
although	NULL
it	NULL
could	NULL
also	NULL
represent	NULL
an	NULL
alternatively	NULL
spliced	NULL
form	NULL
of	NULL
IxBa	NULL
or	NULL
a	NULL
distinct	NULL
cross-reactive	NULL
form	NULL
.	NULL

Likewise	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
if	NULL
the	NULL
30-kDa	NULL
protein	NULL
maintains	NULL
the	NULL
capacity	NULL
for	NULL
cytoplasmic	NULL
retention	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

If	NULL
the	NULL
30-kDa	NULL
form	NULL
is	NULL
a	NULL
degradation	NULL
product	NULL
of	NULL
IkBa	NULL
,	NULL
then	NULL
the	NULL
total	NULL
pool	NULL
of	NULL
IxBa	NULL
in	NULL
PLB-985	NULL
cells	NULL
would	NULL
be	NULL
greater	NULL
than	NULL
the	NULL
pool	NULL
in	NULL
PLB-IIIB	NULL
cells	NULL
.	NULL

Role	NULL
of	NULL
PKR	NULL
in	NULL
virus-induced	NULL
NF-	NULL
<	NULL
B-binding	NULL
activity	NULL
.	NULL

Both	NULL
acute	NULL
Sendai	NULL
virus	NULL
infection	NULL
and	NULL
chronic	NULL
HIV	NULL
infection	NULL
lead	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
distinct	NULL
NF-kB	NULL
DNA-binding	NULL
activities	NULL
(	NULL
50-52	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
two	NULL
viruses	NULL
may	NULL
converge	NULL
on	NULL
a	NULL
signaling	NULL
pathway	NULL
distinct	NULL
from	NULL
that	NULL
stimulated	NULL
by	NULL
PMA	NULL
or	NULL
TNF-a	NULL
in	NULL
the	NULL
PLB-985	NULL
cell	NULL
model	NULL
.	NULL

One	NULL
common	NULL
point	NULL
at	NULL
which	NULL
the	NULL
infection	NULL
cycle	NULL
of	NULL
these	NULL
viruses	NULL
may	NULL
overlap	NULL
is	NULL
with	NULL
the	NULL
gener-	NULL
5192	NULL
DELUCA	NULL
ET	NULL
AL	NULL
.	NULL

ation	NULL
of	NULL
dsRNA	NULL
during	NULL
viral	NULL
replication	NULL
,	NULL
which	NULL
may	NULL
in	NULL
turn	NULL
activate	NULL
PKR	NULL
(	NULL
34	NULL
,	NULL
58	NULL
)	NULL
.	NULL

PKR	NULL
is	NULL
induced	NULL
by	NULL
IFN	NULL
and	NULL
is	NULL
activated	NULL
by	NULL
binding	NULL
to	NULL
dsRNA	NULL
molecules	NULL
generated	NULL
during	NULL
viral	NULL
infection	NULL
.	NULL

The	NULL
antiviral	NULL
activities	NULL
of	NULL
IFN	NULL
are	NULL
in	NULL
part	NULL
brought	NULL
about	NULL
by	NULL
a	NULL
PKR-mediated	NULL
phosphorylation	NULL
of	NULL
initiation	NULL
factor	NULL
eIF-2a	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
inhibits	NULL
protein	NULL
translation	NULL
.	NULL

Recent	NULL
work	NULL
has	NULL
implicated	NULL
PKR	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
(	NULL
27	NULL
,	NULL
30	NULL
)	NULL
.	NULL

PKR	NULL
phosphorylated	NULL
IxBa	NULL
and	NULL
activated	NULL
NF-	NULL
«	NULL
kB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
cellular	NULL
extracts	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
PKR-depleted	NULL
HeLa	NULL
cells	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
was	NULL
not	NULL
activated	NULL
by	NULL
dsRNA	NULL
[	NULL
poly	NULL
(	NULL
I	NULL
)	NULL
:	NULL
poly	NULL
(	NULL
C	NULL
)	NULL
]	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Increased	NULL
PKR	NULL
activity	NULL
,	NULL
acting	NULL
upstream	NULL
of	NULL
IxBa	NULL
phosphoryla-tion	NULL
,	NULL
is	NULL
a	NULL
possible	NULL
mechanism	NULL
by	NULL
which	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
be	NULL
perpetuated	NULL
in	NULL
chronically	NULL
infected	NULL
cells	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
demonstrated	NULL
that	NULL
expression	NULL
of	NULL
wild-type	NULL
PKR	NULL
but	NULL
not	NULL
dsRNA-binding	NULL
domain	NULL
mutants	NULL
of	NULL
PKR	NULL
stimulated	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
expression	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
PKR	NULL
may	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
two	NULL
potential	NULL
mechanisms	NULL
:	NULL
by	NULL
phosphorylation	NULL
of	NULL
IxB	NULL
or	NULL
by	NULL
inhibition	NULL
of	NULL
de	NULL
novo	NULL
IxB	NULL
protein	NULL
synthesis	NULL
,	NULL
thus	NULL
preventing	NULL
the	NULL
shut-down	NULL
of	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
other	NULL
kinases	NULL
and	NULL
signaling	NULL
pathways	NULL
that	NULL
ultimately	NULL
influence	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
are	NULL
also	NULL
constitutively	NULL
activated	NULL
in	NULL
chronically	NULL
HIV-1-infected	NULL
cells	NULL
(	NULL
53	NULL
)	NULL
.	NULL

HIV-1	NULL
Tat	NULL
protein	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
downregulate	NULL
PKR	NULL
activity	NULL
in	NULL
an	NULL
HIV-infected	NULL
T-cell	NULL
line	NULL
and	NULL
in	NULL
Tat-express-ing	NULL
HeLa	NULL
cells	NULL
(	NULL
55	NULL
)	NULL
,	NULL
although	NULL
this	NULL
observation	NULL
is	NULL
not	NULL
consistently	NULL
observed	NULL
.	NULL

Direct	NULL
physical	NULL
association	NULL
between	NULL
Tat	NULL
and	NULL
PKR	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
in	NULL
HeLa	NULL
cells	NULL
and	NULL
T	NULL
lymphocytes	NULL
has	NULL
been	NULL
recently	NULL
reported	NULL
,	NULL
suggesting	NULL
a	NULL
potential	NULL
mechanism	NULL
by	NULL
which	NULL
HIV	NULL
could	NULL
suppress	NULL
PKR	NULL
activity	NULL
specifically	NULL
and	NULL
the	NULL
interferon	NULL
system	NULL
in	NULL
general	NULL
(	NULL
32	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
our	NULL
results	NULL
indicate	NULL
that	NULL
PKR	NULL
mRNA	NULL
,	NULL
protein	NULL
,	NULL
and	NULL
enzymatic	NULL
levels	NULL
are	NULL
up-regulated	NULL
in	NULL
HIV-infected	NULL
monocytic	NULL
cells	NULL
;	NULL
low-level	NULL
IFN	NULL
production	NULL
in	NULL
HIV-l-infected	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
sufficient	NULL
to	NULL
activate	NULL
PKR	NULL
activity	NULL
.	NULL

PKR	NULL
may	NULL
also	NULL
be	NULL
more	NULL
active	NULL
in	NULL
HIV-infected	NULL
cells	NULL
since	NULL
HIV	NULL
TAR	NULL
RNA	NULL
can	NULL
activate	NULL
PKR	NULL
kinase	NULL
activity	NULL
in	NULL
vitro	NULL
(	NULL
16	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
underway	NULL
to	NULL
directly	NULL
implicate	NULL
PKR	NULL
in	NULL
the	NULL
modulation	NULL
of	NULL
HIV-1	NULL
infection	NULL
and	NULL
NF-kB	NULL
activation	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Ron	NULL
Hay	NULL
for	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
the	NULL
IxBa	NULL
monoclonal	NULL
antibody	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
supported	NULL
by	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Canada	NULL
and	NULL
NHRDP	NULL
,	NULL
Health	NULL
and	NULL
Welfare	NULL
Canada	NULL
.	NULL

J.H	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
an	NULL
MRC	NULL
Scientist	NULL
award	NULL
,	NULL
C.D	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
National	NULL
Health	NULL
Research	NULL
Development	NULL
Program	NULL
Fellowship	NULL
,	NULL
and	NULL
AR	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
Studentship	NULL
from	NULL
FCAR	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Alkalay	NULL
,	NULL
L.	NULL
,	NULL
A.	NULL
Yaron	NULL
,	NULL
A.	NULL
Hatzubai	NULL
,	NULL
S.	NULL
Jung	NULL
,	NULL
A.	NULL
Avraham	NULL
,	NULL
O.	NULL
Gerlitz	NULL
,	NULL
I.	NULL
Pashut-Lavon	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1995	NULL
.	NULL

In	NULL
vivo	NULL
stimulation	NULL
of	NULL
IB	NULL
phosphorylation	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
NF-kB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:1294-1301	NULL
.	NULL

2	NULL
.	NULL

Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1991	NULL
.	NULL

HIV	NULL
enhancer	NULL
activity	NULL
perpetuated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
on	NULL
infection	NULL
of	NULL
monocytes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
350:709-712	NULL
.	NULL

3	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698	NULL
.	NULL

4	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217	NULL
.	NULL

5	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
65-kDa	NULL
subunit	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
and	NULL
a	NULL
target	NULL
for	NULL
v-rel-mediated	NULL
repression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1875-1879	NULL
.	NULL

6	NULL
.	NULL

Beauparlant	NULL
,	NULL
P.	NULL
,	NULL
I	NULL
Kwan	NULL
,	NULL
R.	NULL
Bitar	NULL
,	NULL
P.	NULL
Chou	NULL
,	NULL
A.	NULL
E.	NULL
Koromilas	NULL
,	NULL
N.	NULL
Sonenberg	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1994	NULL
.	NULL

Disruption	NULL
of	NULL
IxBa	NULL
«	NULL
regulation	NULL
by	NULL
antisense	NULL
RNA	NULL
expression	NULL
leads	NULL
to	NULL
malignant	NULL
transformation	NULL
.	NULL

Oncogene	NULL
9:3189-3197	NULL
.	NULL

7	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

The	NULL
IxB	NULL
proteins	NULL
:	NULL
multifunctional	NULL
regulators	NULL
of	NULL
Rel/NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2064-2070	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
R.	NULL
I.	NULL
Scheinman	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1992	NULL
.	NULL

IxB	NULL
interacts	NULL
with	NULL
the	NULL
nuclear	NULL
localization	NULL
sequences	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
cytoplasmic	NULL
retention	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1899-1913.	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1992	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
related	NULL
proteins	NULL
:	NULL
Rel/dorsal	NULL
homologies	NULL
meet	NULL
ankyrin-like	NULL
repeats	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17	NULL
:	NULL
135-140	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
mitogen-inducible	NULL
gene	NULL
encoding	NULL
a	NULL
xB	NULL
DNA-binding	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
ref	NULL
oncogene	NULL
and	NULL
to	NULL
cell-cycle	NULL
motifs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:76-80	NULL
.	NULL

Bull	NULL
,	NULL
P.	NULL
,	NULL
K.	NULL
L.	NULL
Morley	NULL
,	NULL
M.	NULL
F.	NULL
Hoekstra	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
mouse	NULL
c-Rel	NULL
protein	NULL
has	NULL
an	NULL
N-terminal	NULL
regulatory	NULL
domain	NULL
and	NULL
a	NULL
C-terminal	NULL
transcriptional	NULL
transactivation	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:5473-5485	NULL
.	NULL

Chen	NULL
,	NULL
Z.	NULL
,	NULL
J.	NULL
Hagler	NULL
,	NULL
V.	NULL
J.	NULL
Palombella	NULL
,	NULL
F.	NULL
Melandri	NULL
,	NULL
D.	NULL
Scherer	NULL
,	NULL
D.	NULL
Ballard	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

Signal-induced	NULL
site-specific	NULL
phosphorylation	NULL
targets	NULL
IxBa	NULL
to	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1586-1597	NULL
.	NULL

D'Addario	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Roulston	NULL
,	NULL
M.	NULL
A.	NULL
Wainberg	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1990	NULL
.	NULL

Coordinate	NULL
enhancement	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1-infected	NULL
promonocytic	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:6080-6089	NULL
.	NULL

D'Addario	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
A.	NULL
Wainberg	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
HIV-1	NULL
infected	NULL
myelomonoblastic	NULL
cells	NULL
by	NULL
phorbol	NULL
ester	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:1222-1229	NULL
.	NULL

DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
F.	NULL
Mercurio	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
IxBa	NULL
precedes	NULL
but	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
its	NULL
dissociation	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:1302-1311	NULL
.	NULL

Edery	NULL
,	NULL
I.	NULL
,	NULL
R.	NULL
Petryshyn	NULL
,	NULL
and	NULL
N.	NULL
Sonenberg	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
double-stranded	NULL
RNA-dependent	NULL
kinase	NULL
(	NULL
dsl	NULL
)	NULL
by	NULL
the	NULL
TAR	NULL
region	NULL
of	NULL
HIV-1	NULL
mRNA	NULL
:	NULL
a	NULL
novel	NULL
translational	NULL
control	NULL
mechanism	NULL
.	NULL

Cell	NULL
56:303-312	NULL
.	NULL

Englund	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
D.	NULL
Hoggan	NULL
,	NULL
T.	NULL
S.	NULL
Theodore	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Martin	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
novel	NULL
HIV-1	NULL
isolate	NULL
containing	NULL
alterations	NULL
affecting	NULL
the	NULL
NF-kB	NULL
element	NULL
.	NULL

Virology	NULL
181:150-157	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Biswas	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
L.	NULL
M.	NULL
Carlson	NULL
,	NULL
K.	NULL
D.	NULL
Brown	NULL
,	NULL
M.	NULL
Tomita-Yamaguchi	NULL
,	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
family	NULL
of	NULL
serine	NULL
proteases	NULL
expressed	NULL
exclusively	NULL
in	NULL
myelo-monocytic	NULL
cells	NULL
specifically	NULL
processes	NULL
the	NULL
nuclear	NULL
factor-xB	NULL
subunit	NULL
of	NULL
p65	NULL
in	NULL
vitro	NULL
and	NULL
may	NULL
impair	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1445-1456	NULL
.	NULL

Gazzolo	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
K.	NULL
Mace	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
HIV1	NULL
replication	NULL
in	NULL
promonocytic	NULL
U937	NULL
cells	NULL
.	NULL

Res	NULL
.	NULL

Virol	NULL
.	NULL

141:259-265	NULL
.	NULL

Grimm	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
P.	NULL
Baeuerle	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
structure-function	NULL
relationship	NULL
of	NULL
its	NULL
protein	NULL
subunits	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

290:297-308	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
U.	NULL
Zabel	NULL
,	NULL
K.	NULL
van	NULL
Zee	NULL
,	NULL
J.	NULL
M.	NULL
Miller	NULL
,	NULL
E.	NULL
Fanning	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1992	NULL
.	NULL

Intramolecular	NULL
masking	NULL
of	NULL
the	NULL
nuclear	NULL
location	NULL
signal	NULL
and	NULL
dimerization	NULL
domain	NULL
in	NULL
the	NULL
precursor	NULL
for	NULL
the	NULL
p50	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
.	NULL

Cell	NULL
68:1121-1133	NULL
.	NULL

Hiscott	NULL
,	NULL
J.	NULL
,	NULL
K.	NULL
Cantell	NULL
,	NULL
and	NULL
C.	NULL
Weissmann	NULL
.	NULL

1984	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
human	NULL
interferon	NULL
genes	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12:3727-3746	NULL
.	NULL

Ho	NULL
,	NULL
W.-Z	NULL
.	NULL

,	NULL
R.	NULL
Cherukuri	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Douglas	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
macrophage	NULL
and	NULL
HIV-1	NULL
.	NULL

Immunol	NULL
.	NULL

Ser	NULL
.	NULL

60:569-587	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
I.	NULL
,	NULL
L.	NULL
D.	NULL
Kerr	NULL
,	NULL
L.	NULL
J.	NULL
Ransone	NULL
,	NULL
E.	NULL
Bengal	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1991.	NULL
c-rel	NULL
activates	NULL
but	NULL
v-rel	NULL
suppresses	NULL
transcription	NULL
from	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:3715-3719	NULL
.	NULL

24a.Jacqué	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
B.	NULL
Fernandez	NULL
,	NULL
F.	NULL
Ar	NULL
Seisdedos	NULL
,	NULL
D.	NULL
Th	NULL
F.	NULL
Baleux	NULL
,	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

J.-L.	NULL
Virelizier	NULL
,	NULL
and	NULL
F.	NULL
Bachelerie	NULL
.	NULL

1996	NULL
.	NULL

Permanent	NULL
occupancy	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
enhancer	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
needed	NULL
for	NULL
persistent	NULL
viral	NULL
replication	NULL
in	NULL
monocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:2930-2938.	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
NF-kB	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
ref	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Koromilas	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
S.	NULL
Roy	NULL
,	NULL
G.	NULL
N.	NULL
Barber	NULL
,	NULL
M.	NULL
G.	NULL
Katze	NULL
,	NULL
and	NULL
N.	NULL
Sonenberg	NULL
.	NULL

1992	NULL
.	NULL

Malignant	NULL
transformation	NULL
by	NULL
a	NULL
mutant	NULL
of	NULL
the	NULL
IFN-inducible	NULL
dsRNA-dependent	NULL
protein	NULL
kinase	NULL
.	NULL

Science	NULL
257:1685-1689	NULL
.	NULL

Kumar	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
Haque	NULL
,	NULL
J.	NULL
Lacoste	NULL
,	NULL
J.	NULL
Hiscott	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
G.	NULL
Williams	NULL
.	NULL

1994	NULL
.	NULL

Double-stranded	NULL
RNA-dependent	NULL
protein	NULL
kinase	NULL
activates	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
phosphorylating	NULL
IxB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:6288-6292	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
R.	NULL
Schmidt-Ullrich	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1993	NULL
.	NULL

Promoter	NULL
analysis	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
IxBo/MAD-3	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
positive	NULL
regulation	NULL
by	NULL
members	NULL
of	NULL
the	NULL
rel/NF-	NULL
«	NULL
B	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:5043-5049	NULL
.	NULL

Locardi	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Petrini	NULL
,	NULL
G.	NULL
Boccoli	NULL
,	NULL
U.	NULL
Testa	NULL
,	NULL
C.	NULL
Dieffenbach	NULL
,	NULL
S.	NULL
Butto	NULL
,	NULL
and	NULL
F.	NULL
Belardelli	NULL
.	NULL

1990	NULL
.	NULL

Increased	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
expression	NULL
in	NULL
chronically	NULL
infected	NULL
U937	NULL
cells	NULL
upon	NULL
in	NULL
vitro	NULL
differentiation	NULL
by	NULL
hydroxyvi-tamin	NULL
D3	NULL
:	NULL
roles	NULL
of	NULL
interferon	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
in	NULL
regulation	NULL
of	NULL
HIV	NULL
production	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:5874-5882	NULL
.	NULL

Maran	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
K.	NULL
Maitra	NULL
,	NULL
A.	NULL
Kumar	NULL
,	NULL
B.	NULL
Dong	NULL
,	NULL
W.	NULL
Xiao	NULL
,	NULL
G.	NULL
Li	NULL
,	NULL
B.	NULL
R.	NULL
G.	NULL
Williams	NULL
,	NULL
P.	NULL
Torrence	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Silverman	NULL
.	NULL

1994	NULL
.	NULL

Blockage	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
signalling	NULL
by	NULL
selective	NULL
ablation	NULL
of	NULL
an	NULL
mRNA	NULL
target	NULL
by	NULL
2-5	NULL
antisense	NULL
chi-meras	NULL
.	NULL

Science	NULL
265:789-792	NULL
.	NULL

McElhinny	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
S.	NULL
MacMorran	NULL
,	NULL
G.	NULL
D.	NULL
Bren	NULL
,	NULL
R.	NULL
M.	NULL
Ten	NULL
,	NULL
A.	NULL
Israel	NULL
,	NULL
and	NULL
voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

C.	NULL
V.	NULL
Paya	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
IxBa	NULL
and	NULL
p105	NULL
in	NULL
monocytes	NULL
and	NULL
macrophages	NULL
persistently	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:1500-1509	NULL
.	NULL

McMillan	NULL
,	NULL
N.	NULL
A.	NULL
J.	NULL
,	NULL
R.	NULL
F.	NULL
Chun	NULL
,	NULL
D.	NULL
P.	NULL
Siderovski	NULL
,	NULL
J.	NULL
Galabru	NULL
,	NULL
W.	NULL
M.	NULL
Toone	NULL
,	NULL
C.	NULL
E.	NULL
Samuel	NULL
,	NULL
T.	NULL
W.	NULL
Mak	NULL
,	NULL
A.	NULL
G.	NULL
Hovanessian	NULL
,	NULL
K.-T.	NULL
Jeang	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
G.	NULL
Williams	NULL
.	NULL

1995	NULL
.	NULL

HIV-1	NULL
Tat	NULL
directly	NULL
interacts	NULL
with	NULL
the	NULL
interferon-induced	NULL
,	NULL
double-stranded	NULL
RNA-dependent	NULL
kinase	NULL
,	NULL
PKR	NULL
.	NULL

Virology	NULL
213:413-424	NULL
.	NULL

Meltzer	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
H.	NULL
E.	NULL
Gendelman	NULL
.	NULL

1992	NULL
.	NULL

Mononuclear	NULL
phagocytes	NULL
as	NULL
targets	NULL
,	NULL
tissue	NULL
reservoirs	NULL
,	NULL
and	NULL
immunoregulatory	NULL
cells	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
disease	NULL
.	NULL

Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immuno	NULL
.	NULL

181:239-263	NULL
.	NULL

Meurs	NULL
,	NULL
E.	NULL
,	NULL
K.	NULL
Chong	NULL
,	NULL
J.	NULL
Galabru	NULL
,	NULL
B.	NULL
R.	NULL
G.	NULL
Williams	NULL
,	NULL
and	NULL
A.	NULL
Hovanessian	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
double-stranded	NULL
RNA-activated	NULL
protein	NULL
kinase	NULL
induced	NULL
by	NULL
interferon	NULL
.	NULL

Cell	NULL
62:379-390	NULL
.	NULL

Meurs	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
N.	NULL
McMillan	NULL
,	NULL
B.	NULL
R.	NULL
G.	NULL
Williams	NULL
,	NULL
A.	NULL
G.	NULL
Hovanessian	NULL
,	NULL
and	NULL
P.	NULL
J	NULL
.	NULL

Southern	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
PKR	NULL
transfected	NULL
into	NULL
murine	NULL
cells	NULL
stimulates	NULL
expression	NULL
of	NULL
genes	NULL
under	NULL
control	NULL
of	NULL
the	NULL
HIV1	NULL
or	NULL
HTLV-1	NULL
LTR	NULL
.	NULL

Virology	NULL
214:653-659	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
H.	NULL
Hatada	NULL
,	NULL
H.	NULL
P.	NULL
Hohmann	NULL
,	NULL
M.	NULL
Haiker	NULL
,	NULL
C.	NULL
Bartsch	NULL
,	NULL
U.	NULL
Roth-lisberger	NULL
,	NULL
H.	NULL
W.	NULL
Lahm	NULL
,	NULL
E.	NULL
J.	NULL
Schlaeger	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
Van	NULL
Loon	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
human	NULL
nuclear	NULL
factor	NULL
xB	NULL
:	NULL
the	NULL
level	NULL
of	NULL
its	NULL
mRNA	NULL
is	NULL
strongly	NULL
regulated	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:966-970	NULL
.	NULL

Molina	NULL
,	NULL
J.-M.	NULL
,	NULL
D.	NULL
T.	NULL
Scadden	NULL
,	NULL
R.	NULL
Burn	NULL
,	NULL
C.	NULL
A.	NULL
Dinarello	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Groopman	NULL
.	NULL

1989	NULL
.	NULL

Production	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interleukin	NULL
1	NULL
beta	NULL
by	NULL
monocytic	NULL
cells	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

84:733-737	NULL
.	NULL

Mosborg-Petersen	NULL
,	NULL
P.	NULL
,	NULL
F.	NULL
D.	NULL
Toth	NULL
,	NULL
V.	NULL
Zachar	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Villadsen	NULL
,	NULL
N.	NULL
NOrskov-Lauritsen	NULL
,	NULL
G.	NULL
Aboagye-Mathiesen	NULL
,	NULL
J.-C.	NULL
Chermann	NULL
,	NULL
and	NULL
P.	NULL
Ebbesen	NULL
.	NULL

1991	NULL
.	NULL

Differential	NULL
HIV	NULL
replication	NULL
and	NULL
HIV-induced	NULL
interferon	NULL
production	NULL
in	NULL
mononuclear	NULL
phagocytes	NULL
:	NULL
relationship	NULL
to	NULL
cell	NULL
maturation	NULL
.	NULL

Res	NULL
.	NULL

Virol	NULL
.	NULL

142	NULL
:	NULL
353-361	NULL
.	NULL

Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
O.	NULL
J.	NULL
Rando	NULL
,	NULL
A.	NULL
L.	NULL
Goldberg	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
ubiquitin-proteosome	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
processing	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
precursor	NULL
protein	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
78:773-785	NULL
.	NULL

Pautrat	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Suzan	NULL
,	NULL
D.	NULL
Salaun	NULL
,	NULL
P.	NULL
Corbeau	NULL
,	NULL
C.	NULL
Allasia	NULL
,	NULL
G.	NULL
Morel	NULL
,	NULL
and	NULL
P.	NULL
Filippi	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
of	NULL
U937	NULL
cells	NULL
promotes	NULL
cell	NULL
differentiation	NULL
and	NULL
a	NULL
new	NULL
pathway	NULL
of	NULL
viral	NULL
assembly	NULL
.	NULL

Virology	NULL
179:749-758	NULL
.	NULL

Pauza	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
J.	NULL
Galindo	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
Richman	NULL
.	NULL

1988	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
of	NULL
monoblastoid	NULL
cells	NULL
:	NULL
cellular	NULL
differentiation	NULL
determines	NULL
the	NULL
pattern	NULL
of	NULL
virus	NULL
replication	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:3558-3564	NULL
.	NULL

Paya	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
R.	NULL
M.	NULL
Ten	NULL
,	NULL
C.	NULL
Bessia	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1992	NULL
.	NULL

NF-	NULL
«	NULL
B-dependent	NULL
induction	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
subunit	NULL
gene	NULL
promoter	NULL
underlies	NULL
self-perpetuation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7826-7830	NULL
.	NULL

Pepin	NULL
,	NULL
N.	NULL
,	NULL
A.	NULL
Roulston	NULL
,	NULL
J.	NULL
Lacoste	NULL
,	NULL
R.	NULL
Lin	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1994	NULL
.	NULL

Subcellular	NULL
redistribution	NULL
of	NULL
HTLV-1-Tax	NULL
protein	NULL
by	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factors	NULL
.	NULL

Virology	NULL
204:706-716	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Distinct	NULL
combinations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
determine	NULL
the	NULL
spec-ificity	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1529-1533	NULL
.	NULL

Petit	NULL
,	NULL
A.	NULL
J.	NULL
C.	NULL
,	NULL
F.	NULL
Terpstra	NULL
,	NULL
and	NULL
F.	NULL
Miedema	NULL
.	NULL

1987	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
down-regulates	NULL
HLA	NULL
class	NULL
II	NULL
expression	NULL
and	NULL
induces	NULL
differentiation	NULL
in	NULL
promonocytic	NULL
U937	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

79:1883-1889	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
role	NULL
of	NULL
monocyte/macrophages	NULL
and	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
REGULATION	NULL
IN	NULL
HIV-1-INFECTED	NULL
MYELOID	NULL
CELLS	NULL
47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

5193	NULL
cytokines	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
HIV	NULL
infection	NULL
.	NULL

Pathobiology	NULL
60:246-251	NULL
.	NULL

Raziuddin	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Mikovits	NULL
,	NULL
I.	NULL
Calvert	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.-F.	NULL
Kung	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
.	NULL

1991	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
expression	NULL
in	NULL
monocytes	NULL
:	NULL
role	NULL
of	NULL
the	NULL
65-kDa	NULL
plus	NULL
50-kDa	NULL
NF-	NULL
«	NULL
B	NULL
dimer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:9426-9430	NULL
.	NULL

Rivicre	NULL
,	NULL
Y.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1991	NULL
.	NULL

Processing	NULL
of	NULL
the	NULL
precursor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
the	NULL
HIV-1	NULL
protease	NULL
during	NULL
acute	NULL
infection	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
350:625-626	NULL
.	NULL

Rodrigues	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
I.	NULL
Michalopoulos	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
and	NULL
R.	NULL
T.	NULL
Hay	NULL
.	NULL

1995	NULL
.	NULL

Inducible	NULL
degradation	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
requires	NULL
the	NULL
acidic	NULL
C-terminal	NULL
domain	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2413-2419	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Beauparlant	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1993	NULL
.	NULL

Chronic	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
stimulates	NULL
distinct	NULL
NF-	NULL
«	NULL
B/rel	NULL
DNA	NULL
binding	NULL
activities	NULL
in	NULL
myelomonoblastic	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:5235-5246	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
L.	NULL
Conti	NULL
,	NULL
V.	NULL
McKiel	NULL
,	NULL
M.	NULL
A.	NULL
Wainberg	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1994	NULL
.	NULL

Virus	NULL
induction	NULL
of	NULL
NF-xB/rel	NULL
proteins	NULL
and	NULL
type	NULL
1	NULL
interferon	NULL
gene	NULL
expression	NULL
in	NULL
myelomonoblastic	NULL
cells	NULL
.	NULL

Leukemia	NULL
8	NULL
(	NULL
Suppl	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
D'Addario	NULL
,	NULL
F.	NULL
Boulerice	NULL
,	NULL
S.	NULL
Caplan	NULL
,	NULL
M.	NULL
Wainberg	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1992	NULL
.	NULL

Induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
and	NULL
NF-	NULL
«	NULL
B-like	NULL
activities	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus-1	NULL
infection	NULL
of	NULL
human	NULL
myelomonoblastic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:751-763	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
Lin	NULL
,	NULL
P.	NULL
Beauparlant	NULL
,	NULL
M.	NULL
A.	NULL
Wainberg	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
HIV-1	NULL
and	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
myeloid	NULL
cells	NULL
by	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

transcription	NULL
factors	NULL
.	NULL

Microbiol	NULL
.	NULL

Rev	NULL
.	NULL

59:481-505	NULL
.	NULL

Roy	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Agy	NULL
,	NULL
A.	NULL
G.	NULL
Hovanessian	NULL
,	NULL
N.	NULL
Sonenberg	NULL
,	NULL
and	NULL
M.	NULL
Katze	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
integrity	NULL
of	NULL
the	NULL
stem	NULL
structure	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Tat-responsive	NULL
sequence	NULL
RNA	NULL
is	NULL
required	NULL
for	NULL
interaction	NULL
with	NULL
the	NULL
interferon-induced	NULL
68,000-M4	NULL
,	NULL
protein	NULL
kinase	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:632-640	NULL
.	NULL

Roy	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
G.	NULL
Katze	NULL
,	NULL
N.	NULL
T.	NULL
Parkin	NULL
,	NULL
I.	NULL
Edery	NULL
,	NULL
A.	NULL
G.	NULL
Hovanessian	NULL
,	NULL
and	NULL
N.	NULL
Sonenberg	NULL
.	NULL

1990	NULL
.	NULL

Control	NULL
of	NULL
the	NULL
interferon-induced	NULL
68-kilodalton	NULL
protein	NULL
kinase	NULL
by	NULL
the	NULL
HIV-1	NULL
tet	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
247:1216-1219	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.	NULL
H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
ref-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-kB	NULL
.	NULL

Science	NULL
251:1490-1493	NULL
.	NULL

Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
P.	NULL
Bull	NULL
,	NULL
M.	NULL
Takamiya	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
U.	NULL
Siebenlist	NULL
,	NULL
P.	NULL
Dobrzanski	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1992	NULL
.	NULL

RelB	NULL
,	NULL
a	NULL
new	NULL
Re	NULL
!	NULL

family	NULL
transcription	NULL
activator	NULL
that	NULL
can	NULL
interact	NULL
with	NULL
p50-NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:674-684	NULL
.	NULL

Samuel	NULL
,	NULL
C.	NULL
E.	NULL
1993	NULL
.	NULL

The	NULL
eIF-2	NULL
«	NULL
protein	NULL
kinases	NULL
,	NULL
regulators	NULL
of	NULL
translation	NULL
in	NULL
eukaryotes	NULL
from	NULL
yeasts	NULL
to	NULL
humans	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:7603-7606	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeverle	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3805-3817	NULL
.	NULL

Suzan	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Salaun	NULL
,	NULL
C.	NULL
Neuveut	NULL
,	NULL
B.	NULL
Spire	NULL
,	NULL
I.	NULL
Hirsch	NULL
,	NULL
P.	NULL
Le	NULL
Bouteiller	NULL
,	NULL
G.	NULL
Querat	NULL
,	NULL
and	NULL
J.	NULL
Sire	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
HIV	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:377-383	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.	NULL
M.	NULL
,	NULL
H.	NULL
L.	NULL
Pabl	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
K.	NULL
N.	NULL
Schmidt	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
human	NULL
IxBa	NULL
«	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
controls	NULL
IxBa	NULL
proteolysis	NULL
and	NULL
NF-B	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
diverse	NULL
stim-uli	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2876-2883	NULL
.	NULL

Ueberla	NULL
,	NULL
K.	NULL
,	NULL
Y.	NULL
C.	NULL
Lu	NULL
,	NULL
E.	NULL
Chung	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
promoter	NULL
.	NULL

J	NULL
.	NULL

Acquired	NULL
Immune	NULL
Defic	NULL
.	NULL

Syndr	NULL
.	NULL

6227-230	NULL
.	NULL

Yamato	NULL
,	NULL
K.	NULL
,	NULL
Z.	NULL
El-Hajjaoui	NULL
,	NULL
K.	NULL
Simon	NULL
,	NULL
and	NULL
H.	NULL
P.	NULL
Koeffler	NULL
.	NULL

1990	NULL
.	NULL

Modulation	NULL
of	NULL
interleukin	NULL
1B	NULL
RNA	NULL
in	NULL
monocytoid	NULL
cells	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

86:1109-1116	NULL
.	NULL

